<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antibiotics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Antibiotics (Basel)</journal-id><journal-id journal-id-type="publisher-id">antibiotics</journal-id><journal-title-group><journal-title>Antibiotics</journal-title></journal-title-group><issn pub-type="epub">2079-6382</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7996626</article-id><article-id pub-id-type="pmid">33668943</article-id><article-id pub-id-type="doi">10.3390/antibiotics10030231</article-id><article-id pub-id-type="publisher-id">antibiotics-10-00231</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Plant-Derivatives Small Molecules with Antibacterial Activity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Alibi</surname><given-names>Sana</given-names></name><xref ref-type="aff" rid="af1-antibiotics-10-00231">1</xref></contrib><contrib contrib-type="author"><name><surname>Crespo</surname><given-names>D&#x000e1;maso</given-names></name><xref ref-type="aff" rid="af2-antibiotics-10-00231">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5735-4668</contrib-id><name><surname>Navas</surname><given-names>Jes&#x000fa;s</given-names></name><xref ref-type="aff" rid="af2-antibiotics-10-00231">2</xref><xref ref-type="aff" rid="af3-antibiotics-10-00231">3</xref><xref rid="c1-antibiotics-10-00231" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Dixon</surname><given-names>Nicholas</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-antibiotics-10-00231"><label>1</label>Analysis and Process Applied to the Environment UR17ES32, Higher Institute of Applied Sciences and Technology, Mahdia 5121, Tunisia; <email>alibi_sana@hotmail.fr</email></aff><aff id="af2-antibiotics-10-00231"><label>2</label>BIOMEDAGE Group, Faculty of Medicine, Cantabria University, 39011 Santander, Spain; <email>crespod@unican.es</email></aff><aff id="af3-antibiotics-10-00231"><label>3</label>Instituto de Investigaci&#x000f3;n Valdecilla (IDIVAL), 39011 Santander, Spain</aff><author-notes><corresp id="c1-antibiotics-10-00231"><label>*</label>Correspondence: <email>navasj@unican.es</email>; Tel.: +34-942-201-943</corresp></author-notes><pub-date pub-type="epub"><day>25</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2021</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>231</elocation-id><history><date date-type="received"><day>18</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>22</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The vegetal world constitutes the main factory of chemical products, in particular secondary metabolites like phenols, phenolic acids, terpenoids, and alkaloids. Many of these compounds are small molecules with antibacterial activity, although very few are actually in the market as antibiotics for clinical practice or as food preservers. The path from the detection of antibacterial activity in a plant extract to the practical application of the active(s) compound(s) is long, and goes through their identification, purification, in vitro and in vivo analysis of their biological and pharmacological properties, and validation in clinical trials. This review presents an update of the main contributions published on the subject, focusing on the compounds that showed activity against multidrug-resistant relevant bacterial human pathogens, paying attention to their mechanisms of action and synergism with classical antibiotics.</p></abstract><kwd-group><kwd>small molecules</kwd><kwd>plant-derivates</kwd><kwd>antibacterial activity</kwd><kwd>multi-drug resistance</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-antibiotics-10-00231"><title>1. Introduction</title><p>There is a wide range of plant species on Earth (400,000&#x02013;500,000 species). Each plant is a small factory of chemical products, notably secondary metabolites, small molecules such as phenolics and polyphenols, terpenoids and essential oils, alkaloids, and others. Therefore, the vegetal world can be considered to be the largest manufacturer of compounds with biological activity, on earth. Many of these compounds show antimicrobial activity, although they do not receive the attention they deserve from doctors or veterinarians, because almost all antibiotics and antivirals on the market are produced by bacteria and fungi or are chemically synthesized. However, the use of plants as therapies against all kinds of ills is a social trend throughout the world, since the 90s of the XX century.</p><p>A considerable number of drugs in use today come from nature, either the microbial world, plants, or animals. The discovery and development of new compounds with pharmacological activity is largely based on the natural world. Approximately 75% of compounds with antibacterial activity introduced into clinical practice in the last 40 years derive from natural products [<xref rid="B1-antibiotics-10-00231" ref-type="bibr">1</xref>]. There is a large body of data describing antimicrobial properties of plant extracts and constituents. The majority of these studies utilize unfractionated extracts that usually show weak in vitro antimicrobial activity. These studies were rarely confirmed by means of in vivo assays. Therefore, the precise action mechanism(s) of the large majority of such phytochemicals are unknown.</p><p>Since they are sessile organisms, plants developed the ability to synthesize compounds with a wide variety of colors, odors, and functions, which allow them to interact with the environment, as well as defend themselves from the attack of microorganisms and parasites [<xref rid="B2-antibiotics-10-00231" ref-type="bibr">2</xref>]. The development as antimicrobials of most of the compounds from the plant world is complicated, due to their weak activity or their pharmacokinetic properties (difficulty of absorption in the gastro-intestinal tract or rapid metabolism). However, improvement of their biological and pharmacological properties can be achieved through structural modifications.</p><p>Numerous articles reporting on the antimicrobial activity of extracts of many plants are published, although fewer publications refer to the activity of specific molecules and their mechanism of action. In this review, we focus on the antibacterial activity of small molecules of vegetal origin against human pathogenic bacteria, in particular multi-drug resistant clinical strains, describing their mechanism of action (when known), and highlighting their anti-virulence properties. It mainly includes contributions published in the last 20 years.</p></sec><sec id="sec2-antibiotics-10-00231"><title>2. Plant Phenols</title><p>Phenols are the largest group of secondary metabolites in plants, encompassing compounds such as simple phenols, phenolic acids, quinones, flavonoids, coumarins, lignans, and others. Their structure includes one or more hydroxyl (-OH) groups directly attached to an aromatic ring [<xref rid="B3-antibiotics-10-00231" ref-type="bibr">3</xref>]. They are synthesized mainly from L-phenylalanine and L-tyrosine, through the shikimate pathway. Plant phenolics are weak acids due to the presence of aromatic rings and the hydroxyl phenolic group. They are acknowledged as strong natural antioxidants playing a key role in a wide range of biological and pharmacological properties like antimicrobial, anti-inflammatory, anticancer, antiallergic, and many more [<xref rid="B4-antibiotics-10-00231" ref-type="bibr">4</xref>]. The antimicrobial activity of plant secondary metabolites is associated to the -OH group(s) attached to the phenol ring. The aromaticity can also be responsible for this effect [<xref rid="B4-antibiotics-10-00231" ref-type="bibr">4</xref>]. Numerous phenolic compounds possess antibacterial activity.</p><sec id="sec2dot1-antibiotics-10-00231"><title>2.1. Simple Phenols</title><p>Catechol and pyrogallol are hydroxylated phenols shown to be toxic to microorganisms. Catechol has two -OH groups, whereas pyrogallol has three (<xref ref-type="fig" rid="antibiotics-10-00231-f001">Figure 1</xref>). Increased hydroxylation results in increased antibacterial activity [<xref rid="B5-antibiotics-10-00231" ref-type="bibr">5</xref>]. Several studies revealed the antiseptic and antimicrobial properties of pyrogallol. Catechol and pyrogallol showed activity against several Gram-positive and Gram-negative bacteria causing periodontitis [<xref rid="B6-antibiotics-10-00231" ref-type="bibr">6</xref>], pyrogallol-based compounds being more active. Simple phenols interact with sulfhydryl groups of microbial enzymes, leading to their inhibition [<xref rid="B7-antibiotics-10-00231" ref-type="bibr">7</xref>]. Eugenol is a hydroxyphenyl propene (<xref ref-type="fig" rid="antibiotics-10-00231-f001">Figure 1</xref>). It is a pale yellow, oily liquid, present in the essential oils of several plants, especially clove, nutmeg, and cinnamon. It is used as a flavoring agent in both food and cosmetics. Eugenol shows excellent antimicrobial activity against a wide range of Gram-negative and Gram-positive bacteria, including multi-drug resistant clinical isolates [<xref rid="B8-antibiotics-10-00231" ref-type="bibr">8</xref>].</p><p>Resveratrol (3,5,4&#x02032;-trihydroxystilbene) (<xref ref-type="fig" rid="antibiotics-10-00231-f001">Figure 1</xref>) is a natural polyphenol that is member of the stilbene family [<xref rid="B9-antibiotics-10-00231" ref-type="bibr">9</xref>]. It is found in the grapes used for winemaking (<italic>Vitis vinifera</italic>) and in many other plants like peanuts (<italic>Arachis hypogea</italic>), blueberries, and cranberries (<italic>Vaccinium</italic> spp.) [<xref rid="B10-antibiotics-10-00231" ref-type="bibr">10</xref>]. It is a phytoalexin synthesized by plants, in response to damage produced by fungal invasion [<xref rid="B11-antibiotics-10-00231" ref-type="bibr">11</xref>]. Resveratrol exits as cis or trans isomer, the trans isomer being the most abundant and more stable of the two isomeric forms. From the end of XX century resveratrol became a popular molecule due to its potential health benefits [<xref rid="B12-antibiotics-10-00231" ref-type="bibr">12</xref>]. In addition to extensive investigations on several disorders like cancer and vascular diseases, resveratrol is studied for its antimicrobial properties. The antibacterial properties of resveratrol were recently revised [<xref rid="B13-antibiotics-10-00231" ref-type="bibr">13</xref>]. Resveratrol showed inhibitory activity in vitro against a wide range of pathogens, including Gram-positive and Gram-negative bacteria. However, for many species, the concentrations required to inhibit bacterial growth are higher than 100 mg/L [<xref rid="B13-antibiotics-10-00231" ref-type="bibr">13</xref>]. The expression of virulence traits, such as biofilm formation and bacterial motility is modified by resveratrol [<xref rid="B13-antibiotics-10-00231" ref-type="bibr">13</xref>]. The bacterial susceptibility to traditional antibiotics can be increased in the presence of resveratrol [<xref rid="B13-antibiotics-10-00231" ref-type="bibr">13</xref>]. In humans, after oral administration, resveratrol is well absorbed and rapidly metabolized [<xref rid="B14-antibiotics-10-00231" ref-type="bibr">14</xref>]. Therefore, it cannot reach the plasma concentrations required for antibacterial activity. This circumstance limits this route of administration in clinical practice, considering the inhibitory concentrations required [<xref rid="B15-antibiotics-10-00231" ref-type="bibr">15</xref>]. A trial to improve bioavailability through intravenous administration revealed that resveratrol is also rapidly metabolized [<xref rid="B16-antibiotics-10-00231" ref-type="bibr">16</xref>] However, the required bactericidal concentrations can be achieved via topical administration. Thus, a positive effect of resveratrol on lesion reduction in human acne vulgaris was observed [<xref rid="B17-antibiotics-10-00231" ref-type="bibr">17</xref>].</p></sec><sec id="sec2dot2-antibiotics-10-00231"><title>2.2. Phenolic Acids</title><p>Phenolic acids or phenol-carboxylic acids are a family of organic compounds with a structure including a phenolic ring and a carboxylic acid group [<xref rid="B18-antibiotics-10-00231" ref-type="bibr">18</xref>] (<xref ref-type="fig" rid="antibiotics-10-00231-f002">Figure 2</xref>).</p><p>The simplest of the members of this family is benzoic acid (BA), an aromatic carboxylic acid with a carboxyl group attached to a phenyl ring. Benzoic acid, benzoates, and benzoic acid esters are found in most fruits, particularly in berries (particularly in blueberries), mushrooms, cinnamon, and clove. Cinnamic acid (CinA) [(E)--3-phenylprop-2-enoic acid)] is an unsaturated monocarboxylic acid encompassing an acrylic acid carrying a phenyl substituent at the 3-position. It occurs as both cis and trans isomer in nature, although the trans isomer is more common. It is obtained from cinnamon oil and is also found in Shea butter. It is a precursor for the synthesis of more complex phenolic compounds: <italic>p</italic>-coumaric acid (<italic>p</italic>-CA), (4-hydroxycinnamic acid), is one of the three hydroxyl derivatives of CinA that differ by the position of the hydroxy substitution of the phenyl group. Caffeic acid (CFA), (E)-3-(3,4-dihidroxifenil)-prop-2-enoic acid, is also a hydroxyl derivative of CinA in which the phenyl ring is substituted by -OH groups at positions 3 and 4. It exists in cis and trans configurations, although the latter is more common. CFA is found in all plants because it is a key intermediate in biosynthesis of lignin. Furthermore, it acts as building block of a variety of plant metabolites. Rosmarinic acid (RA) is an ester of CFA and 3,4-dihydroxyphenyllactic acid that includes five hydroxyl groups in its chemical structure. Chicoric acid (ChA), (2<italic>R</italic>,3<italic>R</italic>)-2,3-bis{[(<italic>E</italic>)-3-(3,4-dihydroxyphenyl)-prop-2-enoyl]oxy}butanedioic acid, is a tartaric acid ester of two CFA molecules. It possesses six hydroxyl groups in its structure. Its most abundant form in nature is L-chicoric acid.</p><p>Phenolic acids are used as food preservatives, due to their recognized antibacterial and antifungal activities, for example BA (E210). The antimicrobial potential of each compound is related to the number of -OH and methoxy (-OCH<sub>3</sub>) groups present in the structure [<xref rid="B19-antibiotics-10-00231" ref-type="bibr">19</xref>]. Thanks to their character of weak acids, they can diffuse through the bacterial membrane and acidify the cytoplasm, leading to cell death. [<xref rid="B20-antibiotics-10-00231" ref-type="bibr">20</xref>]. Consequently, pK<sub>a</sub> and lipophilicity are key parameters in the initial assessment of their bactericidal properties [<xref rid="B9-antibiotics-10-00231" ref-type="bibr">9</xref>]. For example, CFA has a propene side chain, which makes it much more hydrophobic than, for example, protocatechuic acid. CFA lipophilicity facilitates its transport across bacterial cell membrane [<xref rid="B21-antibiotics-10-00231" ref-type="bibr">21</xref>].</p><p>Some phenolic acids showed an antimicrobial activity similar to antibiotics. CFA showed comparable activity to ampicillin against <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic>. Additionally, gallic acid exhibited a good effect against a large group of bacteria including <italic>Enterococcus faecalis, Pseudomonas aeruginosa</italic>, <italic>S. aureus</italic>, <italic>Moraxella catarrhalis</italic>, <italic>Streptococcus agalactiae</italic>, <italic>Campylobacter</italic> sp., <italic>Listeria monocytogenes</italic>, and <italic>Streptococcus pneumoniae</italic> [<xref rid="B22-antibiotics-10-00231" ref-type="bibr">22</xref>]. In another study, many phenolic acids including protocatechuic acid, 4-hydroxybenzoic acid, vanillic acid, syringic acid, CFA, p-coumaric, and ferulic acids contained in wild Polish mushrooms, showed intermediate antibacterial activities against a panel of Gram-positive and Gram-negative bacteria [<xref rid="B23-antibiotics-10-00231" ref-type="bibr">23</xref>].</p><p>Propolis is a sticky, greenish-brown substance produced by bees and used as a coating to build their hives. Propolis contains more than 300 compounds, including phenolic acids and phenolic aldehydes, as well as flavonoids and quinones. Based on its composition, it is thought that propolis has antimicrobial properties. Ethanol extracts of propolis collected from apiaries located in different Polish regions showed moderate activity against <italic>S. aureus</italic> [<xref rid="B24-antibiotics-10-00231" ref-type="bibr">24</xref>]. In addition, the extracts eradicated staphylococcal biofilm. When some of the extracts were combined with antibiotics inhibitors of protein synthesis (amikacin, kanamycin, gentamycin, tetracycline, and fusidic acid), a synergistic anti-staphylococcal effect was observed.</p><p>Hydrochloric extracts of <italic>Pomegranate granatum,</italic> which are rich in phenolics and anthocyanins, showed activity against Gram-positive and Gram-negative bacteria, including <italic>P. aeruginosa</italic> and <italic>S. aureus</italic>, with MIC values ranging between 30 and &#x0003e;90 mg/L [<xref rid="B25-antibiotics-10-00231" ref-type="bibr">25</xref>].</p><p>Methyl gallate from <italic>Galla rhois</italic> originated from Asia exhibited strong activity against <italic>Salmonella</italic> sp. [<xref rid="B26-antibiotics-10-00231" ref-type="bibr">26</xref>]. Synergistic interaction between methyl gallate and tylosine against <italic>S</italic>. <italic>typhimurium</italic> was reported [<xref rid="B27-antibiotics-10-00231" ref-type="bibr">27</xref>]. This combination is a promising option to combat <italic>S</italic>. <italic>typhimurium</italic> in swine and, indirectly, safeguard the health of the public.</p><p>Hyperoside, catechin, CFA, ferulic acid, rutin, and ellagic acid found in extracts from 3 <italic>Potentilla</italic> species showed good antibacterial activity against Gram-positive and Gram-negative bacteria [<xref rid="B28-antibiotics-10-00231" ref-type="bibr">28</xref>].</p><p>Pentagalloylglucopyranose contained in the extract of the seed kernels of <italic>Mangifera indica</italic> displayed a synergism with penicillin G against methicillin-resistant <italic>S. aureus</italic> (MRSA) [<xref rid="B29-antibiotics-10-00231" ref-type="bibr">29</xref>].</p><p>The gallic acid potentially enhanced the activity of sulfamethoxazole, streptomycin, and tetracycline against several <italic>P</italic>. <italic>aeruginosa</italic> isolates, by altering the cell wall integrity [<xref rid="B30-antibiotics-10-00231" ref-type="bibr">30</xref>].</p></sec><sec id="sec2dot3-antibiotics-10-00231"><title>2.3. Quinones</title><p>Quinones possess a fully conjugated cyclic dione structure [<xref rid="B31-antibiotics-10-00231" ref-type="bibr">31</xref>] (<xref ref-type="fig" rid="antibiotics-10-00231-f003">Figure 3</xref>). In general, they resulted from the oxidation of hydroquinones [<xref rid="B32-antibiotics-10-00231" ref-type="bibr">32</xref>]. Hydroxylated amino acids might be converted into quinones, in the presence of suitable enzymes.</p><p>These compounds are omnipresent in the environment&#x02014;plants, fungi, lichens, bacteria, algae, viruses, insects, and higher organisms [<xref rid="B31-antibiotics-10-00231" ref-type="bibr">31</xref>]. The carbonyl functions existing in quinones are related to the redox properties and are responsible for their activities [<xref rid="B32-antibiotics-10-00231" ref-type="bibr">32</xref>]. Quinones are highly reactive electrophilic molecules that can covalently modify a variety of cellular nucleophiles. They react with functional groups of proteins or amino acids such as sulfhydryl, amine, amide, indole, and imidazole substituents. Primary products are Schiff bases, which are transformed to N-quinonyl derivatives or S-quinonyl derivatives, by 1,4-Michael addition via nitrogen or sulfur and to aldehydes in Strecker degradation [<xref rid="B33-antibiotics-10-00231" ref-type="bibr">33</xref>]. The browning reaction of fruits and vegetables caused by cut or injury is the consequence of the formation of quinone-amino acids conjugates, which are colored. [<xref rid="B34-antibiotics-10-00231" ref-type="bibr">34</xref>]. The same mechanism explains the staining propriety of henna [<xref rid="B35-antibiotics-10-00231" ref-type="bibr">35</xref>]. Quinones also participate in the melanin synthesis process in human skin [<xref rid="B34-antibiotics-10-00231" ref-type="bibr">34</xref>].</p><p>The majority of quinones found in plants are relatively simple benzoquinones, naphthoquinones or anthraquinones, although less common skeletal structures are also found to occur, such as terpenoid quinones and higher polycyclic quinones [<xref rid="B36-antibiotics-10-00231" ref-type="bibr">36</xref>]. The benzoquinones are groups of compounds containing two carbonyl groups on a saturated hexacyclic aromatic ring system. The naphthoquinones and anthraquinones derived from fungi and higher plants. The naphthoquinones are characterized by their naphthalene nucleus with two carbonyl groups on one nucleus. While anthraquinones contain the anthracene nucleus with two carbonyl groups, polyquinones are dimers of the different types of quinones. Some of them are of mixed origin.</p><p>Quinones possess great antimicrobial activity. These compounds are able to form irreversible complexes with amino acids in proteins, which lead to their inactivation. Thus, they target cell wall constituents including surface-exposed adhesins, cell wall polypeptides, and membrane-bound enzymes [<xref rid="B37-antibiotics-10-00231" ref-type="bibr">37</xref>]. They can also make substrates elusive to the microorganisms. In particular, 1,4-naphthoquinones show a great antibacterial potency and are promising agents for the treatment of bacterial infections.</p><p>Ravichandiran et al. [<xref rid="B38-antibiotics-10-00231" ref-type="bibr">38</xref>] demonstrated that synthesized naphthoquinones have a good antibacterial effect against <italic>S. aureus</italic>, <italic>L. monocytogenes</italic>, <italic>E. coli</italic>, <italic>P. aeruginosa</italic>, and <italic>Klebsiella pneumoniae</italic>, with MICs values ranging between 15.6 and 500 mg/L. Some naphthoquinones extracted from <italic>Newbouldia laevis</italic> showed good activity against <italic>Bacillus subtilis</italic>, and <italic>E. coli</italic>. Unfortunately, naphthoquinones are toxic for living organisms, which limits their medical application [<xref rid="B32-antibiotics-10-00231" ref-type="bibr">32</xref>].</p><p>Emodin, which is a natural anthraquinone derivative, occurs in many widely used Chinese medicinal herbs. It possesses a wide spectrum of pharmacological properties [<xref rid="B39-antibiotics-10-00231" ref-type="bibr">39</xref>]. This molecule might be a potent antibacterial agent against Gram-positive bacteria, including MRSA and mycobacteria [<xref rid="B39-antibiotics-10-00231" ref-type="bibr">39</xref>]. However, emodin could also lead to hepatotoxicity, kidney toxicity, and reproductive toxicity, particularly in high doses and with long-term use.</p><p>Thymoquinone is an active principle of <italic>Nigella sativa</italic> seed. It exhibited a significant bactericidal activity against Gram-positive cocci. This compound was able to inhibit biofilm formation and to prevent the adhesion of bacteria to glass slides surface [<xref rid="B40-antibiotics-10-00231" ref-type="bibr">40</xref>].</p><p>Two studies [<xref rid="B41-antibiotics-10-00231" ref-type="bibr">41</xref>,<xref rid="B42-antibiotics-10-00231" ref-type="bibr">42</xref>] revealed the bacteriostatic effect of anthraquinones for a wide range of bacteria such as <italic>Bacillus anthracis, Corynebacterium pseudodiphtheriticum,</italic> and <italic>P. aeruginosa,</italic> and bactericidal activity against <italic>Pseudomonas pseudomallei</italic>.</p><p>Quinones present in <italic>Lawsonia inermis,</italic> originated from Oman henna, demonstrated antibacterial activity against <italic>P. aeruginosa</italic> [<xref rid="B43-antibiotics-10-00231" ref-type="bibr">43</xref>]. Henna leaves extracts were active against <italic>S. aureus</italic> and <italic>E. coli</italic> [<xref rid="B44-antibiotics-10-00231" ref-type="bibr">44</xref>].</p><p>Sudhir et al. [<xref rid="B45-antibiotics-10-00231" ref-type="bibr">45</xref>] demonstrated that thymoquinone, thymohydroquinones, and dithymoquinone from <italic>Nigella sativa</italic> seeds have a good potency against <italic>S. aureus, Streptococcus mutans</italic>, and <italic>Streptococcus mitis</italic>.</p><p>The seeds of <italic>Annona squamosa</italic> are also rich in quinones, and exhibited a good antimicrobial effect against <italic>S. aureus</italic>, <italic>E. faecalis</italic>, <italic>Staphylococcus epidermidis</italic>, <italic>E. coli</italic>, and <italic>P. aeruginosa</italic> [<xref rid="B46-antibiotics-10-00231" ref-type="bibr">46</xref>].</p></sec><sec id="sec2dot4-antibiotics-10-00231"><title>2.4. Flavonoids</title><p>Flavonoids are naturally occurring phenolic compounds named as 2-phenyl-1-benzopyran-4-one and classified into several subclasses, according to their basic chemical structures, such as isoflavone, flavones, flavanols, flavonols, flavanones, flavanonols, catechins, and anthocyanidins [<xref rid="B47-antibiotics-10-00231" ref-type="bibr">47</xref>] (<xref ref-type="fig" rid="antibiotics-10-00231-f004">Figure 4</xref>). Almost 5000 known flavonoids are components of a wide variety of edible plants, fruit and vegetables, bearing phenyl chromanone backbone (C6&#x02013;C3&#x02013;C6) with -OH substitution. Therefore, flavonoids constitute a huge group of bioactive substances with a low systemic toxicity. Some flavonoids possess antimicrobial activity against a wide array of microorganisms.</p><sec id="sec2dot4dot1-antibiotics-10-00231"><title>2.4.1. Flavones</title><p>Flavones are omnipresent in photosynthetic cells. They are present in fruit, vegetables, nuts, seeds, stems, and flowers. One of its main functions is protective action against microbial attacks. Due to this protective role, flavones are widely used in traditional medicine to combat infectious diseases [<xref rid="B48-antibiotics-10-00231" ref-type="bibr">48</xref>]. Flavones are used as efflux pump inhibitors, mainly in Gram-positive bacteria [<xref rid="B49-antibiotics-10-00231" ref-type="bibr">49</xref>]. Two plant-derived compounds, the flavonolignan 5&#x02032;-methoxyhydnocarpin-D, and the porphyrin pheo-phorbide, are potent inhibitors of the NorA multi-drug resistant (MDR) efflux pump in <italic>S. aureus</italic> [<xref rid="B50-antibiotics-10-00231" ref-type="bibr">50</xref>]. They did not exhibit any activity by themselves, but potentiated growth inhibitory activity of the plant antibacterial alkaloid berberine [<xref rid="B51-antibiotics-10-00231" ref-type="bibr">51</xref>], the fluoroquinolone norfloxacin [<xref rid="B52-antibiotics-10-00231" ref-type="bibr">52</xref>], and the antiseptic benzalkonium chloride [<xref rid="B53-antibiotics-10-00231" ref-type="bibr">53</xref>] against multidrug-resistant <italic>S. aureus.</italic></p><p>Apigenin and luteolin, two of the most ubiquitous plant flavones, showed moderate activity (MIC = 500 mg/L) against clinical strains of 4 bacterial species [<xref rid="B54-antibiotics-10-00231" ref-type="bibr">54</xref>]. They were more active against Gram-negative (<italic>E. coli</italic> and <italic>P. aeruginosa</italic>) than Gram-positive (<italic>E. faecalis</italic> and <italic>S. aureus</italic>) bacteria. The presence of -OH groups in the phenyl rings A (C-5, C-7) and B (C-3&#x02032;, C-4&#x02032;) did not influence the activity level of flavones. Equally, the presence and position of the sugar group in the flavone glycosides generally had no effect on the MIC values.</p><p>Acacetin (<xref ref-type="fig" rid="antibiotics-10-00231-f003">Figure 3</xref>) is an O-methylated flavone present in many plants and dietary sources with various biological properties, including antimicrobial activity [<xref rid="B55-antibiotics-10-00231" ref-type="bibr">55</xref>]. Acacetin is present in, among others, <italic>Tunera diffusa, Propolis, Dracocephalum moldavica, Betula pendula, Robinia pseudoacacia, Flos Chrysanthemi Indici, Chrysanthemum, Safflower, Calamintha</italic> and <italic>Linaria</italic> species. Acacetin is widely reported for a broad range of antimicrobial activity. Acacetin at 64 mg/L showed synergistic effects with norfloxacin, reducing its minimum inhibitory concentration (MIC) by two-fold [<xref rid="B56-antibiotics-10-00231" ref-type="bibr">56</xref>]. It showed pronounced antibacterial activity against clinically isolated MRSA [<xref rid="B57-antibiotics-10-00231" ref-type="bibr">57</xref>], by inhibiting the activity of sortase A protein [<xref rid="B58-antibiotics-10-00231" ref-type="bibr">58</xref>], and restrained inhibition against <italic>E. faecalis, E. coli,</italic> and <italic>P. aeruginosa</italic> [<xref rid="B59-antibiotics-10-00231" ref-type="bibr">59</xref>]. It also reduced the growth of <italic>Actinomyces naeslundii, Actinomyces israelii, Actinobacillus</italic> sp., <italic>Prevotella intermedia,</italic> and <italic>Porphyromonas gingivalis</italic>, but without effects against <italic>Aggregatibacter actinomicecomitans</italic> [<xref rid="B60-antibiotics-10-00231" ref-type="bibr">60</xref>].</p></sec><sec id="sec2dot4dot2-antibiotics-10-00231"><title>2.4.2. Catechins</title><p>Tea is produced principally in Asian countries from ground dried leaves or buds of the <italic>Camelia sinensis</italic> plant. It is considered that tea with the most highly beneficial active ingredients for human health is green tea. Polyphenols are the biologically active components of green tea. Among them, the most medically relevant are the catechins and the theaflavins. The term catechin is commonly used to refer to the subgroup of flavan-3-ols (or simply flavanols) of flavonoids. The name of catechin comes from the family of plants called catechu (<italic>Terra Japonica</italic>) and specifically from the juice extracted from the Mimosa catechu (<italic>Acacia catechu</italic>). There are four main catechins in green tea: (&#x02013;)-epicatechin (EC), (-)-epigallocatechin, (EGC), epicatechin-3-gallate (ECG), and (-)-epigallocatechin-3-gallate (EGCG). Four theaflavins [theaflavin (TF), theaflavin-3-gallate (TF3G), theaflavin-3&#x02032;-gallate (TF3&#x02032;G), and theaflavin-3,3&#x02032;-digallate (TF33&#x02032;G)] are formed by oxidative dimerization of catechins after harvest [<xref rid="B61-antibiotics-10-00231" ref-type="bibr">61</xref>] (<xref ref-type="fig" rid="antibiotics-10-00231-f005">Figure 5</xref>).</p><p>Teas possess a broad-spectrum antimicrobial activity, but their precise limits are difficult to define, due to variation in the method of testing used. Antibacterial effects of tea were demonstrated against <italic>S. aureus</italic>, <italic>E. coli</italic>, <italic>Vibrio cholerae</italic>, <italic>Shigella</italic> spp., <italic>Salmonella</italic> spp., <italic>Klebsiella</italic> spp., <italic>P. aeruginosa</italic>, and <italic>Bacillus</italic> spp. [<xref rid="B62-antibiotics-10-00231" ref-type="bibr">62</xref>]. However, they are only effective at very high MICs (0.5&#x02013;1 g/L) that are unattainable in vivo, as a consequence of their weak antibacterial activity. Galloylated catechins, at moderate concentrations (3 mg/L) are able to phenotypically transform MRSA from full beta-lactam resistance (MIC = 256&#x02013;512 mg/L) to complete susceptibility (MIC = 1 mg/L) [<xref rid="B63-antibiotics-10-00231" ref-type="bibr">63</xref>]. Reversible conversion to susceptibility is mediated by a complex mechanism after intercalation of these compounds into the bacterial cytoplasm membrane, eliciting dispersal of the proteins associated with cell wall peptidoglycan synthesis, in the presence of beta-lactam antibiotics [<xref rid="B62-antibiotics-10-00231" ref-type="bibr">62</xref>]. The use of these molecules in combination with suitable beta-lactam agents to treat MRSA infections seems feasible.</p><p>The relationships between structure and antibacterial activities of green tea catechins were recently reviewed [<xref rid="B64-antibiotics-10-00231" ref-type="bibr">64</xref>]. There are 6 main antibacterial mechanisms&#x02014;(i) inhibition of virulence factors (toxins and extracellular matrix); (ii) cell wall and cell membrane disruption; (iii) inhibition of intracellular enzymes; (iv) oxidative stress; (v) DNA damage; and (vi) iron chelation. The highest antibacterial activity was observed for galloylated compounds (EGCG, ECG, and theaflavin digallate). Catechins share a common binding mode, characterized by the formation of hydrogen bonds and hydrophobic interactions with their target.</p><p>EGCG, the major polyphenol of green tea, strongly inhibits the formation of certain kinds of biofilm, principally those that use amyloid fibers and pEtN-cellulose as principal extracellular matrix components [<xref rid="B65-antibiotics-10-00231" ref-type="bibr">65</xref>].</p></sec></sec><sec id="sec2dot5-antibiotics-10-00231"><title>2.5. Tannins</title><p>Tannins are complex polymers or oligomers found in almost all plant organs [<xref rid="B66-antibiotics-10-00231" ref-type="bibr">66</xref>]. They regroup hydrolysable tannins (HTs), which are generally multiple esters of gallic acid with a carbohydrate (normally glucose), and condensed tannins or proanthocyanidins, which are derived from flavonoid monomers. Tannins might also be formed by the polymerization of quinone units [<xref rid="B2-antibiotics-10-00231" ref-type="bibr">2</xref>].</p><p>HTs can be roughly grouped into two main categories&#x02014;gallotannins and ellagitannins. They are formed by esterification of gallic acid or ellagic acids with a hydroxyl group of glucose. The antimicrobial activities of HTs were associated with the hydrolysis of the ester bond after ripening of many edible fruits [<xref rid="B67-antibiotics-10-00231" ref-type="bibr">67</xref>]. HTs also show considerable synergy with antibiotics. However, they have low pharmacokinetic property [<xref rid="B68-antibiotics-10-00231" ref-type="bibr">68</xref>].</p><p>Proanthocyanidins (PAs) are condensed tannins with several pharmacological properties, including antibacterial activity [<xref rid="B69-antibiotics-10-00231" ref-type="bibr">69</xref>]. PAs are abundantly available in flowers, fruits, nuts, bark, and seeds [<xref rid="B69-antibiotics-10-00231" ref-type="bibr">69</xref>]. They constitute a molecular defense of plants against biotic and abiotic stressors. They are oligomers and polymers made of catechin and epicatechin as building blocks. Berries are very rich in PAs, in particular lingonberry, cranberry, black currant, and blueberry [<xref rid="B70-antibiotics-10-00231" ref-type="bibr">70</xref>]. The astringency of some unripe fruits, such as persimmon, banana, carob bean, and Chinese quince, is due to their high content in PAs. Medlar, plum, apricot, walnut, and pomegranate are other fruits with high PA content [<xref rid="B71-antibiotics-10-00231" ref-type="bibr">71</xref>].</p><p>PA dimers are found to be potent antimicrobial agents [<xref rid="B72-antibiotics-10-00231" ref-type="bibr">72</xref>]. Different PAs isolated from the stems of <italic>Ephedra sinica</italic> showed antibacterial activity against either <italic>P. aeruginosa</italic> (MIC = 0.0835 mM) or MRSA (MIC = 0.0817 mM) [<xref rid="B73-antibiotics-10-00231" ref-type="bibr">73</xref>]. The viable <italic>L. monocytogenes</italic> cell count were reduced by means of a grape seed extract rich in PAs [<xref rid="B74-antibiotics-10-00231" ref-type="bibr">74</xref>]. PAs exhibited anti-adherence property towards MDR strains of uropathogenic P-fimbriae-expressing <italic>E. coli</italic> [<xref rid="B75-antibiotics-10-00231" ref-type="bibr">75</xref>]. Cranberry extract rich in PAs reduced virulence and inhibited quorum sensing of <italic>P. aeruginosa</italic> in the model host <italic>Drosophila melanogaster</italic> [<xref rid="B76-antibiotics-10-00231" ref-type="bibr">76</xref>]. PA trimer present in the peanut skin disrupts cell wall integrity of <italic>Bacillus cereus</italic> [<xref rid="B77-antibiotics-10-00231" ref-type="bibr">77</xref>]. Ellura, a proanthocyanidin-rich commercial product from cranberry, is commonly used for prevention of urinary tract infections (UTIs) [<xref rid="B78-antibiotics-10-00231" ref-type="bibr">78</xref>].</p></sec></sec><sec id="sec3-antibiotics-10-00231"><title>3. Terpenoids</title><p>Most plants synthesize and release terpenes, volatile compounds that perform various ecological functions and have significant environmental impact [<xref rid="B79-antibiotics-10-00231" ref-type="bibr">79</xref>]. They constitute a family of low molecular weight compounds with an important influence on human life, due to their applications in medicine, food, and cosmetics. Essential oils are terpene-related secondary metabolites responsible of the fragrance of plants [<xref rid="B80-antibiotics-10-00231" ref-type="bibr">80</xref>]. Terpenes are polymers of isoprene (C<sub>5</sub>H<sub>8</sub>) and can be classified in 8 classes&#x02014;hemiterpenes, monoterpenes, sesquiterpenes, diterpenes, sesterterpenes, triterpenes, tetraterpenes, and polyterpenes, which differ in the number of isoprene units. Terpenoids are synthesized from acetate units and contain additional elements (<xref ref-type="fig" rid="antibiotics-10-00231-f006">Figure 6</xref>). Several studies reported the antibacterial effects of terpenoids, including mono-, di-, and triterpenes [<xref rid="B81-antibiotics-10-00231" ref-type="bibr">81</xref>,<xref rid="B82-antibiotics-10-00231" ref-type="bibr">82</xref>].</p><p>The antibacterial mode of action of most terpenoids is related with alterations of the photorespiratory pathway and the photosynthetic machinery caused by the inhibition of the glutamate and aspartate metabolism [<xref rid="B83-antibiotics-10-00231" ref-type="bibr">83</xref>]. Their antibacterial activity was related to&#x02014; (i) the presence of hydroxyl groups; (ii) lipophilicity/hydrophobicity; and (iii) carbonylation of terpenoids [<xref rid="B84-antibiotics-10-00231" ref-type="bibr">84</xref>].</p><p>Twenty-five constituents of essential oils were evaluated against <italic>Mycobacterium tuberculosis</italic> and <italic>Mycobacterium bovis</italic> [<xref rid="B85-antibiotics-10-00231" ref-type="bibr">85</xref>] by the Alamar Blue technique. Carvacrol and thymol were the most active terpenes, with MIC values of 2.02 and 0.78 mg/L, respectively.</p><p>Carvacrol or 2-methyl-5-(1-methylethyl)-phenol (<xref ref-type="fig" rid="antibiotics-10-00231-f006">Figure 6</xref>) is a monoterpenic phenol, biosynthesized from &#x003b3;-terpinene through p-cymene. Carvacrol occurs in aromatic plants and in many essential oils of the <italic>Labiatae</italic> family, including oregano (<italic>Origanum vulgare</italic>), thyme (<italic>Thymus vulgaris</italic>), pepperwort (<italic>Lepidium flavum</italic>), wild bergamot (<italic>Citrus aurantium bergamia</italic>), and others. It is approved as a safe food additive in the USA and Europe and is used as a flavoring agent in sweets, beverages, and chewing gum. Medicinal plants containing carvacrol were used in folk medicine for a long time, even before studies on their therapeutic effectiveness became known. Carvacrol is reported to have a wide variety of biological properties including antimicrobial activity. In this context, two reviews on the most relevant aspect of these activities were previously reported [<xref rid="B86-antibiotics-10-00231" ref-type="bibr">86</xref>,<xref rid="B87-antibiotics-10-00231" ref-type="bibr">87</xref>]. Compared to other volatile compounds present in essential oils, carvacrol shows higher antimicrobial power, due to the phenol ring, which confers hydrophobicity, and the presence of the free hydroxyl group. Carvacrol is active against a huge variety of Gram-positive and Gram-negative human pathogenic bacteria, encompassing both planktonic and sessile human pathogens. In particular, it is very effective to control food-borne pathogens, such as <italic>E. coli</italic>, <italic>Salmonella</italic>, and <italic>Bacillus cereus</italic>. Moreover, carvacrol lends itself to being combined with nanomaterials, thus providing an opportunity for the development of new anti-infective substances to prevent biofilm-associated infections [<xref rid="B88-antibiotics-10-00231" ref-type="bibr">88</xref>].</p><p>Thymol (2-isopropyl-5-methylphenol) is a carvacrol isomer also known as &#x0201c;hydroxy cymene&#x0201d;. As for carvacrol, natural sources of thymol are the essential oils extracted from plants of the <italic>Labiatae</italic> family, such as thyme, oregano, etc. The antibacterial activities of thymol were described in detail in a recent review [<xref rid="B89-antibiotics-10-00231" ref-type="bibr">89</xref>]. Thymol possesses antibacterial activity against a wide range of species, including biofilm-embedded microorganisms. However, the practical application of thymol as antibiotic is limited by the high dosage required for bactericide action as well as its toxicity for animal cells. Therefore, specific studies are required to verify if optimal antimicrobial activity can be achieved using non-toxic concentrations.</p></sec><sec id="sec4-antibiotics-10-00231"><title>4. Alkaloids</title><p>Alkaloids are a large and structurally diverse group of secondary metabolites generally synthesized from amino acids, which have in common their basic nature, which allows them to be found either as salts of organic acid or as free bases. Alkaloids are water-soluble at acid pH and are soluble in organic solvents at alkaline pH. The natural sources of alkaloids are plants (they can be found in 300 plant families) as well as bacteria, fungi, and animals [<xref rid="B90-antibiotics-10-00231" ref-type="bibr">90</xref>]. Some plants use them as natural insecticides/pesticides to defend the plant from the damaging action of some insect species. Vegetal alkaloids are mainly synthesized in vascular and herbaceous plants. Alkaloids are unevenly distributed in the plant tissues, some are highly concentrated in the seeds, while other are found in leaves, barks, fruits, and even roots. Different parts of the same plant might contain different types of alkaloids. More than 18,000 alkaloids are discovered to date [<xref rid="B91-antibiotics-10-00231" ref-type="bibr">91</xref>]. Alkaloids are a structurally diverse group of molecules with a unique unifying feature, which is the presence of a basic nitrogen atom that is part of an amine group [a primary amine (RNH<sub>2</sub>), a secondary amine (R<sub>2</sub>NH) or a tertiary amine (R<sub>3</sub>N)] [<xref rid="B92-antibiotics-10-00231" ref-type="bibr">92</xref>]. They can appear as monomeric forms or they can form oligomers. Alkaloids can generally be categorized on the basis of their chemical structure, metabolic pathway, or natural origin, although there is no standard taxonomic classification [<xref rid="B93-antibiotics-10-00231" ref-type="bibr">93</xref>].</p><p>Different biosynthesis pathways drive to three major categories of alkaloids: true-, proto-, and pseudo-alkaloids. Amino acids are the precursors of true- and proto-alkaloids, but they differ in terms of the presence of the N-atom in the heterocycle, respectively. Pseudoalkaloids possess a basic carbon skeleton not derived from an amino acid [<xref rid="B94-antibiotics-10-00231" ref-type="bibr">94</xref>]. Due to their structural complexity and according to their backbone, heterocyclic alkaloids can be divided into 14 subgroups, including indoles, isoquinolines, pyrrolidines, pyrrolizidines, quinolizidines, tropanes, purines, piperidines, and imidazoles [<xref rid="B94-antibiotics-10-00231" ref-type="bibr">94</xref>]. Alkaloids have a wide variety of pharmacological actions, including antibacterial activity. Alkaloids have a proton accepting nitrogen and, on some occasions, several proton-donating amine hydrogens. Therefore, their biological activity is suggested to be related to the property of forming hydrogen bonds with several biomolecules, such as receptors, enzymes, and proteins [<xref rid="B95-antibiotics-10-00231" ref-type="bibr">95</xref>]. As an example, <italic>Datura stramonium</italic> is a well-known plant that contains several alkaloids showing antimicrobial activity against several microorganisms, among them <italic>E. coli</italic> and <italic>P. aeruginosa</italic> [<xref rid="B96-antibiotics-10-00231" ref-type="bibr">96</xref>].</p><p>The antibacterial properties of plant alkaloids were extensively reread in two recent reviews [<xref rid="B97-antibiotics-10-00231" ref-type="bibr">97</xref>,<xref rid="B98-antibiotics-10-00231" ref-type="bibr">98</xref>]. Here, we focus on alkaloids with antibacterial activity specific for multidrug-resistant pathogens.</p><p>Caffeine (<xref ref-type="fig" rid="antibiotics-10-00231-f007">Figure 7</xref>) is a xanthine alkaloid found in the seeds, nuts, or leaves of a number of plants native to Africa, East Asia, and South America, and helps to protect them against herbivory and from competition, by preventing the germination of nearby seeds [<xref rid="B99-antibiotics-10-00231" ref-type="bibr">99</xref>]. The most well-known source of caffeine is the coffee bean, the seed of the <italic>Coffea</italic> plant. The antibacterial activity of coffee extracts against enterobacteria was previously reported [<xref rid="B100-antibiotics-10-00231" ref-type="bibr">100</xref>]. <italic>P. aeruginosa</italic> is a potent biofilm forming organism causing several diseases. Caffeine showed substantial activity against <italic>P. aeruginosa</italic> (MIC = 200 mg/L), and significantly inhibited its biofilm development [<xref rid="B100-antibiotics-10-00231" ref-type="bibr">100</xref>]. Caffeine interferes with the quorum sensing of <italic>P. aeruginosa</italic> by targeting the swarming motility. Molecular docking analysis indicated that caffeine might interact with the quorum sensing proteins, namely LasR and LasI. Thus, caffeine could inhibit the formation of biofilm by interfering with the quorum sensing of the organism. Caffeine is also found to reduce the secretion of virulence factors from <italic>P. aeruginosa</italic> [<xref rid="B100-antibiotics-10-00231" ref-type="bibr">100</xref>].</p><p>Berberine is a quaternary ammonium salt from the protoberberine group of benzylisoquinoline alkaloids (<xref ref-type="fig" rid="antibiotics-10-00231-f007">Figure 7</xref>) found in the roots of plants like <italic>Berberis vulgaris</italic>, <italic>Argemone mexicana</italic>, <italic>Coptis chinensis</italic>, <italic>Mahonia aquifolium</italic>, and others [<xref rid="B101-antibiotics-10-00231" ref-type="bibr">101</xref>]. Berberine is widely used in the clinical treatment of bacterial diarrhea [<xref rid="B102-antibiotics-10-00231" ref-type="bibr">102</xref>]. The mechanism of action of berberine on diarrhea caused by <italic>V. cholerae</italic> and <italic>E. coli</italic> was extensively studied. As early as 1982, berberine was shown to directly inhibit <italic>V. cholerae</italic> and <italic>E. coli</italic> enterotoxins effects in vitro [<xref rid="B103-antibiotics-10-00231" ref-type="bibr">103</xref>]. In <italic>Streptococcus pyogenes</italic>, berberine sulfate interferes with the process of fimbrial formation, inhibiting bacterial adherence to the mucosal or epithelial surfaces [<xref rid="B104-antibiotics-10-00231" ref-type="bibr">104</xref>]. It is difficult to explain the effects of berberine, as although it is a cationic alkaloid, it is poorly soluble in water, which implies a reduced intestinal absorption (in animal models it was observed that the bioavailability of berberine was much lesser than 1%, since that part of the berberine absorbed by the intestine is excreted back into the intestinal lumen through the action of the P-glycoprotein). Berberine also shows antibacterial effect in vitro against <italic>S. aureus</italic> [<xref rid="B105-antibiotics-10-00231" ref-type="bibr">105</xref>]. A combination of berberine and vancomycin was more effective than vancomycin alone for treating <italic>Clostridium difficile</italic> infection in a mice model [<xref rid="B106-antibiotics-10-00231" ref-type="bibr">106</xref>]. While many of the effects of berberine are explained through enzyme / receptor and cell signaling mechanisms, there is growing evidence that these effects are due to an interrelationship between berberine and the gut microbiota, similar to those of probiotics and dietary fiber [<xref rid="B107-antibiotics-10-00231" ref-type="bibr">107</xref>].</p><p>Berberine and CinA can self-assemble, forming nanoparticles (NPs) that display bacteriostatic activity against MRSA and show ability for biofilm elimination [<xref rid="B108-antibiotics-10-00231" ref-type="bibr">108</xref>]. CinA is one of the main components of the traditional spice <italic>Cinnamomi cortex</italic>, widely used in daily life [<xref rid="B109-antibiotics-10-00231" ref-type="bibr">109</xref>]. Berberine-CinA NPs can first spontaneously adhere to the bacterial surface, penetrate into the cell, and then lead to converging attack against MRSA. Bactericidal mechanisms of Berberine-CinA NPs on MRSA were revealed by both transcriptomic and quantitative Polymerase Chain Reaction analysis. Combining the results of these analysis with spectral data and single crystal X-ray diffraction, allowed elucidation of NPs&#x02019; self-assembly mechanism, which was driven by hydrogen bonds and &#x003c0;&#x02212;&#x003c0; stacking interactions. Biocompatibility tests showed that the NPs are nonhemolytic, with little toxicity in vitro and in vivo. This directed self-assembly mode offers a new perspective toward the development of biocompatible plant-based antimicrobial nanomedicines, with potential clinical application.</p><p>Capsaicin (CAP) (8-methyl-N-vanillyl-6-nonenamide) is an alkaloid found in the berries of almost all peppers (<italic>Capsicum</italic> sp.) [<xref rid="B110-antibiotics-10-00231" ref-type="bibr">110</xref>]. CAP is one of the most used spices in cuisines all over the world [<xref rid="B111-antibiotics-10-00231" ref-type="bibr">111</xref>]. In addition to its culinary utilization, CAP is used for pain relief in several serious chronic conditions [<xref rid="B112-antibiotics-10-00231" ref-type="bibr">112</xref>,<xref rid="B113-antibiotics-10-00231" ref-type="bibr">113</xref>].</p><p>Among its multiple benefits for human health, CAP possess antibacterial properties. At concentrations of 12.5&#x02013;50 mg/L, CAP inhibits the <italic>S. aureus</italic> NorA efflux pump, reducing its susceptibility to ciprofloxacin (the MIC was reduced by 2- to 4-fold in presence of capsaicin) and the invasiveness of <italic>S. aureus</italic> in the J774 macrophage cell line [<xref rid="B114-antibiotics-10-00231" ref-type="bibr">114</xref>]. Using a mice virulence model, Qiu et al. demonstrated that capsaicin (dosage 100 mg/Kg) protects mice from pneumonia caused by MRSA [<xref rid="B115-antibiotics-10-00231" ref-type="bibr">115</xref>]. CAP showed moderate bactericide activity (MIC = 64&#x02013;128 mg/L) against a collection of 32 <italic>Streptococcus pyogenes</italic> Italian clinical isolates from children with pharyngitis [<xref rid="B116-antibiotics-10-00231" ref-type="bibr">116</xref>]. At sublethal concentrations (8&#x02013;32 mg/L), capsaicin prevented cell invasion and reduced hemolytic activity, two important virulence features of this pathogen.</p></sec><sec sec-type="conclusions" id="sec5-antibiotics-10-00231"><title>5. Conclusions</title><p>The emergence of antibiotic-resistant microorganisms is a global health threat that limits successful therapeutic management of bacterial infections. It is now essential to develop new strategies to fight antibiotic resistance. The usage of natural compounds derived from plants attracted the attention of multi-disciplinary researchers. These compounds exert their antibacterial activities by means of a variety of mechanisms (<xref ref-type="fig" rid="antibiotics-10-00231-f008">Figure 8</xref>). Some phytochemicals reported in this review are already in use as food preservatives. Nevertheless, most plant-derived molecules are not suitable for development as anti-infective agents for clinical use, because they are effective against important bacterial pathogens, only at concentrations that are unobtainable in vivo. However, some of them show synergistic actions with classical antibiotics. These actions turn them into molecules with a promising future, to be applied in the clinic. The capacity showed by tea galloylated catechins to fully reverse &#x003b2;-lactam resistance in MRSA at low concentrations is remarkable and pave the way for a new generation of compounds that can resolve infections, not due to their antibacterial properties reflected in the MIC but due to their ability to counteract drug resistance machineries. This is an example of how plant-derived compounds can preserve the efficacy of old antibiotics, and consequently restore their clinical application.</p><p>Some compounds showing promising antibacterial properties, such as the mentioned catechins and resveratrol, are rapidly metabolized once they are supplied by the common routes. Their structures can be chemically modified to obtain more acceptable compounds from a pharmaceutical perspective.</p><p>Phytochemicals that are characterized by diverse chemical structures and mechanisms of action are attractive therapeutic tools for discovering new active products. A large amount of information on the antibacterial properties of plant extracts and active molecules has been published so far in this century. Many studies are still needed to shed light on the antibacterial mechanisms and pharmacokinetic properties of plant-derived molecules. It would also be desirable to unify the methods and units used to assess the antibacterial activity of these compounds. For the most promising compounds, the translation of in vitro studies to in vivo experiments and finally to human clinical trials need to be conducted.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>S.A. and J.N. designed the structure of the manuscript. S.A. wrote the first version, which was reviewed and completed by D.C. and J.N. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>Instituto de Investigaci&#x000f3;n Valdecilla (IDIVAL) supported this research (Project INNVAL 20/22).</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>No new data were created or analyzed in this study. Data sharing is not applicable to this article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-antibiotics-10-00231"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title><source>J. Nat. Prod.</source><year>2020</year><volume>83</volume><fpage>770</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref><ref id="B2-antibiotics-10-00231"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>A.</given-names></name><name><surname>Kalske</surname><given-names>A.</given-names></name></person-group><article-title>Plant secondary metabolite diversity and species interactions</article-title><source>Annu. Rev. Ecol. Evol. Syst.</source><year>2018</year><volume>49</volume><fpage>115</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1146/annurev-ecolsys-110617-062406</pub-id></element-citation></ref><ref id="B3-antibiotics-10-00231"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowan</surname><given-names>M.M.</given-names></name></person-group><article-title>Plant products as antimicrobial agents</article-title><source>Clin. Microbiol. Rev.</source><year>1999</year><volume>12</volume><fpage>564</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1128/CMR.12.4.564</pub-id><?supplied-pmid 10515903?><pub-id pub-id-type="pmid">10515903</pub-id></element-citation></ref><ref id="B4-antibiotics-10-00231"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brglez Mojzer</surname><given-names>E.</given-names></name><name><surname>Knez Hrn&#x0010d;i&#x0010d;</surname><given-names>M.</given-names></name><name><surname>&#x00160;kerget</surname><given-names>M.</given-names></name><name><surname>Knez</surname><given-names>&#x0017d;.</given-names></name><name><surname>Bren</surname><given-names>U.</given-names></name></person-group><article-title>Polyphenols: Extraction Methods, Antioxidative Action, Bioavailability and Anticarcinogenic Effects</article-title><source>Molecules</source><year>2016</year><volume>21</volume><elocation-id>901</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21070901</pub-id></element-citation></ref><ref id="B5-antibiotics-10-00231"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Geissman</surname><given-names>T.A.</given-names></name></person-group><article-title>Flavonoid compounds, tannins, lignins, and related compounds</article-title><source>Pyrrole Pigments, Isoprenoid Compounds and Phenolic Plant Constituents</source><person-group person-group-type="editor"><name><surname>Florkin</surname><given-names>M.</given-names></name><name><surname>Stotz</surname><given-names>E.H.</given-names></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1963</year><volume>Volume 9</volume><fpage>265</fpage></element-citation></ref><ref id="B6-antibiotics-10-00231"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrazzano</surname><given-names>G.M.</given-names></name><name><surname>Amato</surname><given-names>I.</given-names></name><name><surname>Ingenito</surname><given-names>A.</given-names></name><name><surname>Zarrelli</surname><given-names>A.</given-names></name><name><surname>Pinto</surname><given-names>G.</given-names></name><name><surname>Pollio</surname><given-names>A.</given-names></name></person-group><article-title>Plant Polyphenols and Their Anti-Cariogenic Properties: A Review</article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>1486</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.3390/molecules16021486</pub-id><?supplied-pmid 21317840?><pub-id pub-id-type="pmid">21317840</pub-id></element-citation></ref><ref id="B7-antibiotics-10-00231"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aldulaimi</surname><given-names>O.A.</given-names></name></person-group><article-title>General Overview of Phenolics from Plant to Laboratory, Good Antibacterials or Not</article-title><source>Pharmacogn. Rev.</source><year>2017</year><volume>11</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.4103/phrev.phrev_43_16</pub-id><?supplied-pmid 28989246?><pub-id pub-id-type="pmid">28989246</pub-id></element-citation></ref><ref id="B8-antibiotics-10-00231"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Barbieri</surname><given-names>R.</given-names></name><name><surname>Coppo</surname><given-names>E.</given-names></name><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Izadi</surname><given-names>M.</given-names></name><name><surname>Abdollahi</surname><given-names>M.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Ajami</surname><given-names>M.</given-names></name></person-group><article-title>Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint</article-title><source>Crit. Rev. Microbiol.</source><year>2017</year><volume>43</volume><fpage>668</fpage><lpage>689</lpage><pub-id pub-id-type="doi">10.1080/1040841X.2017.1295225</pub-id><?supplied-pmid 28346030?><pub-id pub-id-type="pmid">28346030</pub-id></element-citation></ref><ref id="B9-antibiotics-10-00231"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niesen</surname><given-names>D.B.</given-names></name><name><surname>Hessler</surname><given-names>C.</given-names></name><name><surname>Seeram</surname><given-names>N.P.</given-names></name></person-group><article-title>Beyond resveratrol: A review of natural stilbenoids identified from 2009&#x02013;2013</article-title><source>J. Berry Res.</source><year>2013</year><volume>3</volume><fpage>181</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.3233/JBR-130062</pub-id></element-citation></ref><ref id="B10-antibiotics-10-00231"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langcake</surname><given-names>P.</given-names></name><name><surname>Pryce</surname><given-names>R.</given-names></name></person-group><article-title>The production of resveratrol by <italic>Vitis vinifera</italic> and other members of the Vitaceae as a response to infection or injury</article-title><source>Physiol. Plant Pathol.</source><year>1976</year><volume>9</volume><fpage>77</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/0048-4059(76)90077-1</pub-id></element-citation></ref><ref id="B11-antibiotics-10-00231"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adrian</surname><given-names>M.</given-names></name><name><surname>Jeandet</surname><given-names>P.</given-names></name><name><surname>Veneau</surname><given-names>J.</given-names></name><name><surname>Weston</surname><given-names>L.A.</given-names></name><name><surname>Bessis</surname><given-names>R.</given-names></name></person-group><article-title>Biological activity of resveratrol, a stilbenic compound from grapevines, against <italic>Botrytis cinerea</italic>, the causal agent for gray mold</article-title><source>J. Chem. Ecol.</source><year>1997</year><volume>23</volume><fpage>1689</fpage><lpage>1702</lpage><pub-id pub-id-type="doi">10.1023/B:JOEC.0000006444.79951.75</pub-id></element-citation></ref><ref id="B12-antibiotics-10-00231"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smoliga</surname><given-names>J.M.</given-names></name><name><surname>Baur</surname><given-names>J.A.</given-names></name><name><surname>Hausenblas</surname><given-names>H.A.</given-names></name></person-group><article-title>Resveratrol and health&#x02014;A comprehensive review of human clinical trials</article-title><source>Mol. Nutr. Food Res.</source><year>2011</year><volume>55</volume><fpage>1129</fpage><lpage>1141</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201100143</pub-id><pub-id pub-id-type="pmid">21688389</pub-id></element-citation></ref><ref id="B13-antibiotics-10-00231"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestergaard</surname><given-names>M.</given-names></name><name><surname>Ingmer</surname><given-names>H.</given-names></name></person-group><article-title>Antibacterial and antifungal properties of resveratrol</article-title><source>Int. J. Antimicrob. Agents</source><year>2019</year><volume>53</volume><fpage>716</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2019.02.015</pub-id><?supplied-pmid 30825504?><pub-id pub-id-type="pmid">30825504</pub-id></element-citation></ref><ref id="B14-antibiotics-10-00231"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walle</surname><given-names>T.</given-names></name><name><surname>Hsieh</surname><given-names>F.</given-names></name><name><surname>DeLegge</surname><given-names>M.H.</given-names></name><name><surname>Oatis</surname><given-names>J.E.</given-names></name><name><surname>Walle</surname><given-names>U.K.</given-names></name></person-group><article-title>High absorption but very low bioavailability of oral resveratrol in humans</article-title><source>Drug Metab. Dispos.</source><year>2004</year><volume>32</volume><fpage>1377</fpage><lpage>1382</lpage><pub-id pub-id-type="doi">10.1124/dmd.104.000885</pub-id><pub-id pub-id-type="pmid">15333514</pub-id></element-citation></ref><ref id="B15-antibiotics-10-00231"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boocock</surname><given-names>D.J.</given-names></name><name><surname>Faust</surname><given-names>G.E.</given-names></name><name><surname>Patel</surname><given-names>K.R.</given-names></name><name><surname>Schinas</surname><given-names>A.M.</given-names></name><name><surname>Brown</surname><given-names>V.A.</given-names></name><name><surname>Ducharme</surname><given-names>M.P.</given-names></name><name><surname>Booth</surname><given-names>T.D.</given-names></name><name><surname>Crowell</surname><given-names>J.A.</given-names></name><name><surname>Perloff</surname><given-names>M.</given-names></name><name><surname>Gescher</surname><given-names>A.J.</given-names></name><etal/></person-group><article-title>Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent</article-title><source>Cancer Epidemiol. Biomark. Prev.</source><year>2007</year><volume>16</volume><fpage>1246</fpage><lpage>1252</lpage><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-0022</pub-id></element-citation></ref><ref id="B16-antibiotics-10-00231"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottart</surname><given-names>C.H.</given-names></name><name><surname>Nivet-Antoine</surname><given-names>V.</given-names></name><name><surname>Laguillier-Morizot</surname><given-names>C.</given-names></name><name><surname>Beaudeux</surname><given-names>J.L.</given-names></name></person-group><article-title>Resveratrol bioavailability and toxicity in humans</article-title><source>Mol. Nutr. Food Res.</source><year>2010</year><volume>54</volume><fpage>7</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200900437</pub-id><pub-id pub-id-type="pmid">20013887</pub-id></element-citation></ref><ref id="B17-antibiotics-10-00231"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabbrocini</surname><given-names>G.</given-names></name><name><surname>Staibano</surname><given-names>S.</given-names></name><name><surname>De Rosa</surname><given-names>G.</given-names></name><name><surname>Battimiello</surname><given-names>V.</given-names></name><name><surname>Fardella</surname><given-names>N.</given-names></name><name><surname>Ilardi</surname><given-names>G.</given-names></name><name><surname>La Rotonda</surname><given-names>M.I.</given-names></name><name><surname>Longobardi</surname><given-names>A.</given-names></name><name><surname>Mazzella</surname><given-names>M.</given-names></name><name><surname>Siano</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Resveratrol-containing gel for the treatment of acne vulgaris</article-title><source>Am. J. Clin. Dermatol.</source><year>2011</year><volume>12</volume><fpage>133</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.2165/11530630-000000000-00000</pub-id><pub-id pub-id-type="pmid">21348544</pub-id></element-citation></ref><ref id="B18-antibiotics-10-00231"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heleno</surname><given-names>S.A.</given-names></name><name><surname>Martins</surname><given-names>A.</given-names></name><name><surname>Queiroz</surname><given-names>M.J.</given-names></name><name><surname>Ferreira</surname><given-names>I.C.</given-names></name></person-group><article-title>Bioactivity of phenolic acids: Metabolites versus parent compounds: A review</article-title><source>Food Chem.</source><year>2014</year><volume>173</volume><fpage>501</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2014.10.057</pub-id><?supplied-pmid 25466052?><pub-id pub-id-type="pmid">25466052</pub-id></element-citation></ref><ref id="B19-antibiotics-10-00231"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>N.</given-names></name><name><surname>Goel</surname><given-names>N.</given-names></name></person-group><article-title>Phenolic acids: Natural versatile molecules with promising therapeutic applications</article-title><source>Biotechnol. Rep.</source><year>2019</year><volume>24</volume><fpage>e00370</fpage><pub-id pub-id-type="doi">10.1016/j.btre.2019.e00370</pub-id></element-citation></ref><ref id="B20-antibiotics-10-00231"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirshfield</surname><given-names>I.N.</given-names></name><name><surname>Terzulli</surname><given-names>S.</given-names></name><name><surname>O&#x02019;Byrne</surname><given-names>C.</given-names></name></person-group><article-title>Weak organic acids: A panoply of effects on bacteria</article-title><source>Sci. Prog.</source><year>2003</year><volume>86</volume><fpage>245</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.3184/003685003783238626</pub-id><pub-id pub-id-type="pmid">15508892</pub-id></element-citation></ref><ref id="B21-antibiotics-10-00231"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>K&#x00119;pa</surname><given-names>M.</given-names></name><name><surname>Miklasi&#x00144;ska-Majdanik</surname><given-names>M.</given-names></name><name><surname>Wojtyczka</surname><given-names>R.D.</given-names></name><name><surname>Idzik</surname><given-names>D.</given-names></name><name><surname>Korzeniowski</surname><given-names>K.</given-names></name><name><surname>Smole&#x00144;-Dzirba</surname><given-names>J.</given-names></name><name><surname>Wasik</surname><given-names>T.J.</given-names></name></person-group><article-title>Antimicrobial potential of caffeic acid against <italic>Staphylococcus aureus</italic> clinical strains</article-title><source>BioMed Res. Int.</source><year>2018</year><volume>2018</volume><fpage>7413504</fpage><pub-id pub-id-type="doi">10.1155/2018/7413504</pub-id><?supplied-pmid 30105241?><pub-id pub-id-type="pmid">30105241</pub-id></element-citation></ref><ref id="B22-antibiotics-10-00231"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanwitheesuk</surname><given-names>A.</given-names></name><name><surname>Teerawutgulrag</surname><given-names>A.</given-names></name><name><surname>Kilburn</surname><given-names>J.D.</given-names></name><name><surname>Rakariyatham</surname><given-names>N.</given-names></name></person-group><article-title>Antimicrobial gallic acid from <italic>Caesalpinia mimosoides</italic> Lamk</article-title><source>Food Chem.</source><year>2007</year><volume>100</volume><fpage>1044</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2005.11.008</pub-id></element-citation></ref><ref id="B23-antibiotics-10-00231"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowacka</surname><given-names>N.</given-names></name><name><surname>Nowak</surname><given-names>R.</given-names></name><name><surname>Drozd</surname><given-names>M.</given-names></name><name><surname>Olech</surname><given-names>M.</given-names></name><name><surname>Los</surname><given-names>R.</given-names></name><name><surname>Malm</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial, antiradical potential and phenolic compounds of thirty-one Polish mushrooms</article-title><source>PLoS ONE</source><year>2015</year><volume>10</volume><elocation-id>e0140355</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0140355</pub-id><?supplied-pmid 26468946?><pub-id pub-id-type="pmid">26468946</pub-id></element-citation></ref><ref id="B24-antibiotics-10-00231"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grecka</surname><given-names>K.</given-names></name><name><surname>Ku&#x0015b;</surname><given-names>P.M.</given-names></name><name><surname>Oki&#x00144;czyc</surname><given-names>P.</given-names></name><name><surname>Worobo</surname><given-names>R.W.</given-names></name><name><surname>Walkusz</surname><given-names>J.</given-names></name><name><surname>Szweda</surname><given-names>P.</given-names></name></person-group><article-title>The anti-staphylococcal potential of ethanolic Polish propolis extracts</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1732</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24091732</pub-id><?supplied-pmid 31058881?><pub-id pub-id-type="pmid">31058881</pub-id></element-citation></ref><ref id="B25-antibiotics-10-00231"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>A.D.</given-names></name><name><surname>Ozgen</surname><given-names>M.</given-names></name><name><surname>Dayisoylu</surname><given-names>K.S.</given-names></name><name><surname>Erbil</surname><given-names>N.</given-names></name><name><surname>Durgac</surname><given-names>C.</given-names></name></person-group><article-title>Antimicrobial activity of six pomegranate (<italic>Punica granatum</italic> L.) varieties and their relation to some of their pomological and phytonutrient characteristics</article-title><source>Molecules</source><year>2009</year><volume>14</volume><fpage>1808</fpage><lpage>1817</lpage><pub-id pub-id-type="doi">10.3390/molecules14051808</pub-id><?supplied-pmid 19471201?><pub-id pub-id-type="pmid">19471201</pub-id></element-citation></ref><ref id="B26-antibiotics-10-00231"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.</given-names></name><name><surname>Mun</surname><given-names>S.</given-names></name><name><surname>Chahar</surname><given-names>H.S.</given-names></name><name><surname>Bharaj</surname><given-names>P.</given-names></name><name><surname>Kang</surname><given-names>O.</given-names></name><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>D.</given-names></name><name><surname>Kwon</surname><given-names>D.</given-names></name></person-group><article-title>Methyl gallate from <italic>Galla rhois</italic> successfully controls clinical isolates of <italic>Salmonella</italic> infection in both in vitro and in vivo systems</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e102697</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0102697</pub-id><?supplied-pmid 25048362?><pub-id pub-id-type="pmid">25048362</pub-id></element-citation></ref><ref id="B27-antibiotics-10-00231"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mechesso</surname><given-names>A.F.</given-names></name><name><surname>Yixian</surname><given-names>Q.</given-names></name><name><surname>Park</surname><given-names>S.</given-names></name></person-group><article-title>Methyl gallate and tylosin synergistically reduce the membrane integrity and intracellular survival of <italic>Salmonella</italic> Typhimurium</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0221386</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0221386</pub-id><?supplied-pmid 31490973?><pub-id pub-id-type="pmid">31490973</pub-id></element-citation></ref><ref id="B28-antibiotics-10-00231"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Pu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Phytochemical profiles, antioxidant and antimicrobial activities of three <italic>Potentilla</italic> species</article-title><source>BMC Complement. Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>321</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-321</pub-id><pub-id pub-id-type="pmid">24252124</pub-id></element-citation></ref><ref id="B29-antibiotics-10-00231"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiamboonsri</surname><given-names>P.</given-names></name><name><surname>Pithayanukul</surname><given-names>P.</given-names></name><name><surname>Bavovada</surname><given-names>R.</given-names></name><name><surname>Chomnawang</surname><given-names>M.T.</given-names></name></person-group><article-title>The inhibitory potential of Thai mango seed kernel extract against Methicillin-Resistant <italic>Staphylococcus aureus</italic></article-title><source>Molecules</source><year>2011</year><volume>16</volume><fpage>6255</fpage><lpage>6270</lpage><pub-id pub-id-type="doi">10.3390/molecules16086255</pub-id><pub-id pub-id-type="pmid">21788933</pub-id></element-citation></ref><ref id="B30-antibiotics-10-00231"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayaraman</surname><given-names>P.</given-names></name><name><surname>Sakharkar</surname><given-names>M.K.</given-names></name><name><surname>Sing Lim</surname><given-names>C.</given-names></name><name><surname>Hock Tang</surname><given-names>T.</given-names></name><name><surname>Sakharkar</surname><given-names>K.R.</given-names></name></person-group><article-title>Activity and interactions of antibiotic and phytochemical combinations against <italic>Pseudomonas aeruginosa</italic> in vitro</article-title><source>Int. J. Biol. Sci.</source><year>2010</year><volume>6</volume><fpage>556</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.7150/ijbs.6.556</pub-id><pub-id pub-id-type="pmid">20941374</pub-id></element-citation></ref><ref id="B31-antibiotics-10-00231"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Futuro</surname><given-names>D.O.</given-names></name><name><surname>Ferreira</surname><given-names>P.G.</given-names></name><name><surname>Nicoletti</surname><given-names>C.D.</given-names></name><name><surname>Borba-Santos</surname><given-names>L.P.</given-names></name><name><surname>Silva</surname><given-names>F.C.D.</given-names></name><name><surname>Rozental</surname><given-names>S.</given-names></name><name><surname>Ferreira</surname><given-names>V.F.</given-names></name></person-group><article-title>The antifungal activity of naphthoquinones: An integrative review</article-title><source>Ann. Acad. Bras. Cienc.</source><year>2018</year><volume>90</volume><fpage>1187</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1590/0001-3765201820170815</pub-id></element-citation></ref><ref id="B32-antibiotics-10-00231"><label>32.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Eyong</surname><given-names>K.O.</given-names></name><name><surname>Kuete</surname><given-names>V.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Quinones and benzophenones from the medicinal plants of Africa</article-title><source>Medicinal Plant Research in Africa: Pharmacology and Chemistry</source><edition>1st ed.</edition><person-group person-group-type="editor"><name><surname>Kuete</surname><given-names>V.</given-names></name></person-group><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2013</year><fpage>351</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-405927-6.00010-2</pub-id></element-citation></ref><ref id="B33-antibiotics-10-00231"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittner</surname><given-names>S.</given-names></name></person-group><article-title>When quinones meet amino acids: Chemical, physical and biological consequences</article-title><source>Amino Acids</source><year>2006</year><volume>30</volume><fpage>205</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1007/s00726-005-0298-2</pub-id><?supplied-pmid 16601927?><pub-id pub-id-type="pmid">16601927</pub-id></element-citation></ref><ref id="B34-antibiotics-10-00231"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>H.</given-names></name></person-group><article-title>Phenol oxidase (E.I.14.18.1), a marker enzyme for defense cells</article-title><source>Progress in Histochemistry and Cytochemistry</source><publisher-name>Gustav Fischer</publisher-name><publisher-loc>New York, NY, USA</publisher-loc><year>1988</year><volume>Volume 17</volume><fpage>194</fpage></element-citation></ref><ref id="B35-antibiotics-10-00231"><label>35.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fessenden</surname><given-names>R.J.</given-names></name><name><surname>Fessenden</surname><given-names>S.</given-names></name></person-group><source>Organic Chemistry</source><edition>2nd ed.</edition><publisher-name>Willard Grant Press</publisher-name><publisher-loc>Boston, MA, USA</publisher-loc><year>1982</year><fpage>755</fpage></element-citation></ref><ref id="B36-antibiotics-10-00231"><label>36.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Abad Mart&#x000ed;nez</surname><given-names>M.J.</given-names></name><name><surname>Bermejo Benito</surname><given-names>P.</given-names></name></person-group><article-title>Biological activity of quinones</article-title><source>Studies in Natural Products Chemistry</source><comment>Atta-ur-Rahmen</comment><publisher-name>Elsevier</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2005</year><volume>Volume 30</volume><fpage>303</fpage><lpage>366</lpage></element-citation></ref><ref id="B37-antibiotics-10-00231"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>J.L.</given-names></name><name><surname>Hagerman</surname><given-names>A.E.</given-names></name><name><surname>Steinberg</surname><given-names>P.D.</given-names></name><name><surname>Mason</surname><given-names>P.K.</given-names></name></person-group><article-title>Phlorotannin-protein interactions</article-title><source>J. Chem. Ecol.</source><year>1996</year><volume>22</volume><fpage>1887</fpage><lpage>1899</lpage><pub-id pub-id-type="doi">10.1007/BF02028510</pub-id></element-citation></ref><ref id="B38-antibiotics-10-00231"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravichandiran</surname><given-names>P.</given-names></name><name><surname>Sheet</surname><given-names>S.</given-names></name><name><surname>Premnath</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>A.R.</given-names></name><name><surname>Yoo</surname><given-names>D.J.</given-names></name></person-group><article-title>1,4-Naphthoquinone analogues: Potent antibacterial agents and mode of action evaluation</article-title><source>Molecules</source><year>2019</year><volume>11</volume><elocation-id>1437</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24071437</pub-id><?supplied-pmid 30979056?><pub-id pub-id-type="pmid">30979056</pub-id></element-citation></ref><ref id="B39-antibiotics-10-00231"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Fu</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>X.</given-names></name><name><surname>Cao</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>L.</given-names></name><name><surname>Huyiligeqi</surname><given-names>N.J.</given-names></name></person-group><article-title>Emodin: A review of its pharmacology, toxicity and pharmacokinetics</article-title><source>Phytother. Res.</source><year>2016</year><volume>30</volume><fpage>1207</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1002/ptr.5631</pub-id><pub-id pub-id-type="pmid">27188216</pub-id></element-citation></ref><ref id="B40-antibiotics-10-00231"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaieb</surname><given-names>K.</given-names></name><name><surname>Kouidhi</surname><given-names>B.</given-names></name><name><surname>Jrah</surname><given-names>H.</given-names></name><name><surname>Mahdouani</surname><given-names>K.</given-names></name><name><surname>Bakhrouf</surname><given-names>A.</given-names></name></person-group><article-title>Antibacterial activity of Thymoquinone, an active principle of <italic>Nigella sativa</italic> and its potency to prevent bacterial biofilm formation</article-title><source>BMC Complement. Altern. Med.</source><year>2011</year><volume>13</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-11-29</pub-id><?supplied-pmid 21489272?><pub-id pub-id-type="pmid">21489272</pub-id></element-citation></ref><ref id="B41-antibiotics-10-00231"><label>41.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Duke</surname><given-names>J.A.</given-names></name></person-group><source>Handbook of Medicinal Herbs</source><edition>2nd ed.</edition><publisher-name>CRC Press Inc.</publisher-name><publisher-loc>Boca, FL, USA</publisher-loc><year>1985</year></element-citation></ref><ref id="B42-antibiotics-10-00231"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kazmi</surname><given-names>M.H.</given-names></name><name><surname>Malik</surname><given-names>A.</given-names></name><name><surname>Hameed</surname><given-names>S.</given-names></name><name><surname>Akhtar</surname><given-names>N.</given-names></name><name><surname>Noor Ali</surname><given-names>S.</given-names></name></person-group><article-title>An anthraquinone derivative from <italic>Cassia italica</italic></article-title><source>Phytochemistry</source><year>1994</year><volume>36</volume><fpage>761</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1016/S0031-9422(00)89812-X</pub-id></element-citation></ref><ref id="B43-antibiotics-10-00231"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Habbal</surname><given-names>O.</given-names></name><name><surname>Hasson</surname><given-names>S.S.</given-names></name><name><surname>El-Hag</surname><given-names>A.H.</given-names></name><name><surname>Al-Mahrooqi</surname><given-names>Z.</given-names></name><name><surname>Al-Hashmi</surname><given-names>N.</given-names></name><name><surname>Al-Bimani</surname><given-names>Z.</given-names></name><name><surname>Al-Balushi</surname><given-names>M.S.</given-names></name><name><surname>Al-Jabri</surname><given-names>A.A.</given-names></name></person-group><article-title>Antibacterial activity of <italic>Lawsonia inermis</italic> Linn (Henna) against <italic>Pseudomonas aeruginosa</italic></article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2011</year><volume>1</volume><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(11)60021-X</pub-id><pub-id pub-id-type="pmid">23569753</pub-id></element-citation></ref><ref id="B44-antibiotics-10-00231"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathi</surname><given-names>P.V.</given-names></name><name><surname>Ambhore</surname><given-names>D.</given-names></name><name><surname>Jamode</surname><given-names>P.</given-names></name><name><surname>Katkar</surname><given-names>P.</given-names></name><name><surname>Kamble</surname><given-names>P.</given-names></name></person-group><article-title>Antimicrobial activity of Henna leaves against <italic>Staphylococcus aureus</italic> and <italic>Escherichia coli</italic></article-title><source>World J. Pharm. Pharm. Sci.</source><year>2017</year><volume>6</volume><fpage>981</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.20959/wjpps201710-10240</pub-id></element-citation></ref><ref id="B45-antibiotics-10-00231"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudhir</surname><given-names>S.P.</given-names></name><name><surname>Deshmukh</surname><given-names>P.</given-names></name><name><surname>Verma</surname><given-names>H.N.</given-names></name></person-group><article-title>Comparative study of antimicrobial effect of <italic>Nigella sativa</italic> seed extracts from different geographies</article-title><source>Int. J. Pharmacogn.</source><year>2016</year><volume>3</volume><fpage>257</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.13040/IJPSR.0975-8232.IJP.3(6)</pub-id></element-citation></ref><ref id="B46-antibiotics-10-00231"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasser</surname><given-names>M.</given-names></name><name><surname>El-Mestrah</surname><given-names>M.</given-names></name><name><surname>As-sadi</surname><given-names>F.</given-names></name><name><surname>Cheaito</surname><given-names>L.</given-names></name><name><surname>Hijazi</surname><given-names>A.</given-names></name><name><surname>Chokr</surname><given-names>A.</given-names></name><name><surname>Hassan</surname><given-names>R.</given-names></name></person-group><article-title>Antibacterial, antioxidant and antiproliferative activities of the hydroalcoholic extract of the Lebanese <italic>Annona squamosa</italic> L. seeds</article-title><source>Int. Res. J. Pharm.</source><year>2017</year><volume>8</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.7897/2230-8407.08011</pub-id></element-citation></ref><ref id="B47-antibiotics-10-00231"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cazarolli</surname><given-names>L.H.</given-names></name><name><surname>Zanatta</surname><given-names>L.</given-names></name><name><surname>Alberton</surname><given-names>E.H.</given-names></name><name><surname>Figueiredo</surname><given-names>M.S.</given-names></name><name><surname>Folador</surname><given-names>P.</given-names></name><name><surname>Damazio</surname><given-names>R.G.</given-names></name><name><surname>Pizzolatti</surname><given-names>M.G.</given-names></name><name><surname>Silva</surname><given-names>F.R.</given-names></name></person-group><article-title>Flavonoids: Prospective drug candidates</article-title><source>Mini Rev. Med. Chem.</source><year>2008</year><volume>8</volume><fpage>1429</fpage><lpage>1440</lpage><pub-id pub-id-type="doi">10.2174/138955708786369564</pub-id><pub-id pub-id-type="pmid">18991758</pub-id></element-citation></ref><ref id="B48-antibiotics-10-00231"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cushnie</surname><given-names>T.P.T.</given-names></name><name><surname>Lamb</surname><given-names>A.J.</given-names></name></person-group><article-title>Antimicrobial activity of flavonoids</article-title><source>Int. J. Antimicrob. Agents</source><year>2005</year><volume>26</volume><fpage>343</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2005.09.002</pub-id><?supplied-pmid 16323269?><pub-id pub-id-type="pmid">16323269</pub-id></element-citation></ref><ref id="B49-antibiotics-10-00231"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavri</surname><given-names>M.</given-names></name><name><surname>Piddock</surname><given-names>L.J.V.</given-names></name><name><surname>Gibbons</surname><given-names>S.</given-names></name></person-group><article-title>Bacterial efflux pump inhibitors from natural sources</article-title><source>J. Antimicrob. Chemother.</source><year>2007</year><volume>59</volume><fpage>1247</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1093/jac/dkl460</pub-id><?supplied-pmid 17145734?><pub-id pub-id-type="pmid">17145734</pub-id></element-citation></ref><ref id="B50-antibiotics-10-00231"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guz</surname><given-names>N.R.</given-names></name><name><surname>Stermitz</surname><given-names>F.R.</given-names></name><name><surname>Johnson</surname><given-names>J.B.</given-names></name><name><surname>Beeson</surname><given-names>T.D.</given-names></name><name><surname>Willen</surname><given-names>S.</given-names></name></person-group><article-title>Flavonolignan and flavone inhibitors of a <italic>Staphylococcus aureus</italic> multidrug resistance pump: Structure-activity relationships</article-title><source>J. Med. Chem.</source><year>2001</year><volume>44</volume><fpage>261</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1021/jm0004190</pub-id><?supplied-pmid 11170636?><pub-id pub-id-type="pmid">11170636</pub-id></element-citation></ref><ref id="B51-antibiotics-10-00231"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gottesman</surname><given-names>M.M.</given-names></name><name><surname>Pastan</surname><given-names>I.</given-names></name></person-group><article-title>Biochemistry of multidrug resistance mediated by the multidrug transporter</article-title><source>Annu. Rev. Biochem.</source><year>1993</year><volume>62</volume><fpage>385</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.62.070193.002125</pub-id><pub-id pub-id-type="pmid">8102521</pub-id></element-citation></ref><ref id="B52-antibiotics-10-00231"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikaido</surname><given-names>H.</given-names></name></person-group><article-title>Prevention of drug access to bacterial targets: Permeability barriers and active efflux</article-title><source>Science</source><year>1994</year><volume>264</volume><fpage>382</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1126/science.8153625</pub-id><?supplied-pmid 8153625?><pub-id pub-id-type="pmid">8153625</pub-id></element-citation></ref><ref id="B53-antibiotics-10-00231"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neyfakh</surname><given-names>A.A.</given-names></name><name><surname>Borsch</surname><given-names>C.M.</given-names></name><name><surname>Kaatz</surname><given-names>G.W.</given-names></name></person-group><article-title>Fluoroquinolone resistance protein NorA of <italic>Staphylococcus aureus</italic> is a multidrug efflux transporter</article-title><source>Antimicrob. Agents Chemother.</source><year>1993</year><volume>37</volume><fpage>128</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1128/AAC.37.1.128</pub-id><?supplied-pmid 8431010?><pub-id pub-id-type="pmid">8431010</pub-id></element-citation></ref><ref id="B54-antibiotics-10-00231"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamczak</surname><given-names>A.</given-names></name><name><surname>Ozarowski</surname><given-names>M.</given-names></name><name><surname>Karpinski</surname><given-names>T.M.</given-names></name></person-group><article-title>Antibacterial activity of some flavonoids and organic acids widely distributed in plants</article-title><source>J. Clin. Med.</source><year>2020</year><volume>9</volume><elocation-id>109</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9010109</pub-id><?supplied-pmid 31906141?><pub-id pub-id-type="pmid">31906141</pub-id></element-citation></ref><ref id="B55-antibiotics-10-00231"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Gupta</surname><given-names>P.</given-names></name><name><surname>Meena</surname><given-names>A.</given-names></name><name><surname>Luqman</surname><given-names>S.</given-names></name></person-group><article-title>Acacetin, a flavin with diverse therapeutic potential in cancer, inflammation, infections, and other metabolic disorders</article-title><source>Food Chem. Toxicol.</source><year>2020</year><volume>145</volume><fpage>111708</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2020.111708</pub-id><?supplied-pmid 32866514?><pub-id pub-id-type="pmid">32866514</pub-id></element-citation></ref><ref id="B56-antibiotics-10-00231"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname><given-names>R.A.</given-names></name><name><surname>Ramirez</surname><given-names>R.R.A.</given-names></name><name><surname>Maciel</surname><given-names>K.</given-names></name><name><surname>Agra</surname><given-names>M.F.</given-names></name><name><surname>Vanderlei de Souza</surname><given-names>M.F.</given-names></name><name><surname>Falc&#x000e3;o-Silva</surname><given-names>V.S.</given-names></name><name><surname>Siqueira-Junior</surname><given-names>J.P.</given-names></name></person-group><article-title>Phenolic compounds from <italic>Sidastrum micranthum</italic> (A. St.-Hil.) fryxell and evaluation of acacetin and 7,4&#x02032;-Di-O-methylisoscutellarein as modulator of bacterial drug resistance</article-title><source>Quim. Nova</source><year>2011</year><volume>34</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1590/S0100-40422011000800016</pub-id></element-citation></ref><ref id="B57-antibiotics-10-00231"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cha</surname><given-names>J.D.</given-names></name><name><surname>Choi</surname><given-names>S.M.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name></person-group><article-title>Combination of acacetin with antibiotics against Methicillin Resistant <italic>Staphylococcus aureus</italic> isolated from clinical specimens</article-title><source>Adv. Biosci. Biotechnol.</source><year>2014</year><volume>54</volume><fpage>398</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.4236/abb.2014.54048</pub-id></element-citation></ref><ref id="B58-antibiotics-10-00231"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bi</surname><given-names>C.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Zhong</surname><given-names>X.</given-names></name><name><surname>Cai</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name></person-group><article-title>Acacetin protects mice from <italic>Staphylococcus aureus</italic> bloodstream infection by inhibiting of the activity of sortase A</article-title><source>Molecules</source><year>2016</year><volume>10</volume><elocation-id>1285</elocation-id><pub-id pub-id-type="doi">10.3390/molecules21101285</pub-id></element-citation></ref><ref id="B59-antibiotics-10-00231"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komape</surname><given-names>N.P.</given-names></name><name><surname>Aderogba</surname><given-names>M.</given-names></name><name><surname>Bagla</surname><given-names>V.P.</given-names></name><name><surname>Masoko</surname><given-names>P.</given-names></name><name><surname>Eloff</surname><given-names>J.N.</given-names></name></person-group><article-title>Anti-bacterial and anti-oxidant activities of leaf extracts of Combretumvendae (Combretecacea) and the isolation of an anti-bacterial compound</article-title><source>Afr. J. Tradit. Complement. Altern. Med.</source><year>2014</year><volume>11</volume><fpage>73</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.4314/ajtcam.v11i5.12</pub-id></element-citation></ref><ref id="B60-antibiotics-10-00231"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>More</surname><given-names>G.</given-names></name><name><surname>Lall</surname><given-names>N.</given-names></name><name><surname>Hussein</surname><given-names>A.</given-names></name><name><surname>Tshikalange</surname><given-names>T.E.</given-names></name></person-group><article-title>Anti-microbial constituents of <italic>Artemisia afra</italic> Jacq. ex Willd. against periodontal pathogens</article-title><source>Evid. Based Complement. Alter. Med.</source><year>2012</year><volume>2012</volume><fpage>252758</fpage><pub-id pub-id-type="doi">10.1155/2012/252758</pub-id><?supplied-pmid 22693528?><pub-id pub-id-type="pmid">22693528</pub-id></element-citation></ref><ref id="B61-antibiotics-10-00231"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>M.</given-names></name></person-group><article-title>Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas</article-title><source>Mol. Nutr. Food Res.</source><year>2007</year><volume>51</volume><fpage>116</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200600173</pub-id><?supplied-pmid 17195249?><pub-id pub-id-type="pmid">17195249</pub-id></element-citation></ref><ref id="B62-antibiotics-10-00231"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yiannakopolou</surname><given-names>E.C.</given-names></name></person-group><article-title>Recent patents on antibacterial, antifungal and antiviral properties of tea</article-title><source>Recent Pat. Antiinfect. Drug Discov.</source><year>2012</year><volume>7</volume><fpage>60</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.2174/157489112799829738</pub-id><?supplied-pmid 22353001?><pub-id pub-id-type="pmid">22353001</pub-id></element-citation></ref><ref id="B63-antibiotics-10-00231"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>P.W.</given-names></name></person-group><article-title>Interactions of tea-derived catechin gallates with bacterial pathogens</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>1986</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25081986</pub-id></element-citation></ref><ref id="B64-antibiotics-10-00231"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renzetti</surname><given-names>A.</given-names></name><name><surname>Betts</surname><given-names>J.W.</given-names></name><name><surname>Fukumoto</surname><given-names>K.</given-names></name><name><surname>Rutherford</surname><given-names>R.N.</given-names></name></person-group><article-title>Antibacterial green tea catechins from a molecular perspective: Mechanisms of action and structure&#x02013;activity relationships</article-title><source>Food Funct.</source><year>2020</year><volume>11</volume><fpage>9370</fpage><lpage>9396</lpage><pub-id pub-id-type="doi">10.1039/D0FO02054K</pub-id><?supplied-pmid 33094767?><pub-id pub-id-type="pmid">33094767</pub-id></element-citation></ref><ref id="B65-antibiotics-10-00231"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hengge</surname><given-names>R.</given-names></name></person-group><article-title>Targeting bacterial biofilms with green tea polyphenol EGCG</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2403</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24132403</pub-id><?supplied-pmid 31261858?><pub-id pub-id-type="pmid">31261858</pub-id></element-citation></ref><ref id="B66-antibiotics-10-00231"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scalbert</surname><given-names>A.</given-names></name></person-group><article-title>Antimicrobial properties of tannins</article-title><source>Phytochemistry</source><year>1991</year><volume>30</volume><fpage>3875</fpage><lpage>3883</lpage><pub-id pub-id-type="doi">10.1016/0031-9422(91)83426-L</pub-id></element-citation></ref><ref id="B67-antibiotics-10-00231"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>K.T.</given-names></name><name><surname>Wong</surname><given-names>T.Y.</given-names></name><name><surname>Wei</surname><given-names>C.I.</given-names></name><name><surname>Huang</surname><given-names>Y.W.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name></person-group><article-title>Tannins and human health: A review</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>1998</year><volume>38</volume><fpage>421</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1080/10408699891274273</pub-id><pub-id pub-id-type="pmid">9759559</pub-id></element-citation></ref><ref id="B68-antibiotics-10-00231"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekambaram</surname><given-names>S.P.</given-names></name><name><surname>Perumal</surname><given-names>S.S.</given-names></name><name><surname>Balakrishnan</surname><given-names>A.</given-names></name></person-group><article-title>Scope of hydrolysable tannins as possible antimicrobial agent</article-title><source>Phytother. Res.</source><year>2016</year><volume>30</volume><fpage>1035</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1002/ptr.5616</pub-id><?supplied-pmid 27062587?><pub-id pub-id-type="pmid">27062587</pub-id></element-citation></ref><ref id="B69-antibiotics-10-00231"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauf</surname><given-names>A.</given-names></name><name><surname>Imran</surname><given-names>M.</given-names></name><name><surname>Abu-Izneid</surname><given-names>T.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Pan</surname><given-names>X.</given-names></name><name><surname>Naz</surname><given-names>S.</given-names></name><name><surname>Sanches Silva</surname><given-names>A.</given-names></name><name><surname>Saeed</surname><given-names>F.</given-names></name><name><surname>Rasul Suleria</surname><given-names>H.A.</given-names></name></person-group><article-title>Proanthocyanidins, a comprehensive review</article-title><source>Biomed. Pharmacother.</source><year>2019</year><volume>116</volume><fpage>108999</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2019.108999</pub-id><pub-id pub-id-type="pmid">31146109</pub-id></element-citation></ref><ref id="B70-antibiotics-10-00231"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krenn</surname><given-names>L.</given-names></name><name><surname>Steitz</surname><given-names>M.</given-names></name><name><surname>Schlicht</surname><given-names>C.</given-names></name><name><surname>Kurth</surname><given-names>H.</given-names></name><name><surname>Gaedcke</surname><given-names>F.</given-names></name></person-group><article-title>Anthocyanin and proantho-cyanidin-rich extracts of berries in food supplements&#x02013;analysis with problems</article-title><source>Int. J. Pharm. Sci.</source><year>2007</year><volume>62</volume><fpage>803</fpage><lpage>812</lpage></element-citation></ref><ref id="B71-antibiotics-10-00231"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Y.</given-names></name><name><surname>Che</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>B.</given-names></name></person-group><article-title>Analysis of content of proanthocyanidin from featured fruit of Xinjiang</article-title><source>Xinjiang Agric. Sci.</source><year>2009</year><volume>46</volume><fpage>484</fpage><lpage>487</lpage></element-citation></ref><ref id="B72-antibiotics-10-00231"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Bruyne</surname><given-names>T.</given-names></name><name><surname>Pieters</surname><given-names>L.</given-names></name><name><surname>Witvrouw</surname><given-names>M.</given-names></name><name><surname>De Clercq</surname><given-names>E.</given-names></name><name><surname>Vanden Berghe</surname><given-names>D.</given-names></name><name><surname>Vlietinck</surname><given-names>A.J.</given-names></name></person-group><article-title>Biological evaluation of proanthocyanidin dimers and related polyphenols</article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>954</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1021/np980481o</pub-id><?supplied-pmid 10425115?><pub-id pub-id-type="pmid">10425115</pub-id></element-citation></ref><ref id="B73-antibiotics-10-00231"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname><given-names>X.</given-names></name><name><surname>Shang</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Liang</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Mikage</surname><given-names>M.</given-names></name><name><surname>Cai</surname><given-names>S.</given-names></name></person-group><article-title>A-type proanthocyanidins from the stems of <italic>Ephedra sinica</italic> (Ephedraceae) and their antimicrobial activities</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>5172</fpage><lpage>5189</lpage><pub-id pub-id-type="doi">10.3390/molecules18055172</pub-id><pub-id pub-id-type="pmid">23648595</pub-id></element-citation></ref><ref id="B74-antibiotics-10-00231"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>J.</given-names></name><name><surname>Boyer</surname><given-names>R.R.</given-names></name><name><surname>Neilson</surname><given-names>A.P.</given-names></name><name><surname>O&#x02019;Keefe</surname><given-names>S.F.</given-names></name><name><surname>Chu</surname><given-names>H.S.S.</given-names></name><name><surname>Williams</surname><given-names>R.C.</given-names></name><name><surname>Dorenkott</surname><given-names>M.R.</given-names></name><name><surname>Goodrich</surname><given-names>K.M.</given-names></name></person-group><article-title>Evaluation of peanut skin and grape seed extracts to inhibit growth of foodborne pathogens</article-title><source>Food Sci. Nutr.</source><year>2020</year><volume>8</volume><fpage>6174</fpage><lpage>6181</lpage><pub-id pub-id-type="doi">10.1002/fsn3.503</pub-id><?supplied-pmid 29188040?><pub-id pub-id-type="pmid">33282268</pub-id></element-citation></ref><ref id="B75-antibiotics-10-00231"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonz&#x000e1;lez de Llano</surname><given-names>D.</given-names></name><name><surname>Esteban-Fern&#x000e1;ndez</surname><given-names>A.</given-names></name><name><surname>S&#x000e1;nchez-Pat&#x000e1;n</surname><given-names>F.</given-names></name><name><surname>Mart&#x000ed;n-&#x000c1;lvarez</surname><given-names>P.J.</given-names></name><name><surname>Moreno-Arribas</surname><given-names>M.V.</given-names></name><name><surname>Bartolom&#x000e9;</surname><given-names>B.</given-names></name></person-group><article-title>Anti-adhesive activity of cranberry phenolic compounds and their microbial-derived metabolites against uropathogenic <italic>Escherichia coli</italic> in bladder epithelial cell cultures</article-title><source>Int. J. Mol. Sci.</source><year>2015</year><volume>16</volume><fpage>12119</fpage><lpage>12130</lpage><pub-id pub-id-type="doi">10.3390/ijms160612119</pub-id><?supplied-pmid 26023719?><pub-id pub-id-type="pmid">26023719</pub-id></element-citation></ref><ref id="B76-antibiotics-10-00231"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maisuria</surname><given-names>V.B.</given-names></name><name><surname>Lopez-de Los Santos</surname><given-names>Y.</given-names></name><name><surname>Tufenkji</surname><given-names>N.</given-names></name><name><surname>D&#x000e9;ziel</surname><given-names>E.</given-names></name></person-group><article-title>Cramberry-derived proanthocyanidins impair virulence and inhibit quorum sensing of <italic>Pseudomonas aeruginosa</italic></article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>30169</fpage><pub-id pub-id-type="doi">10.1038/srep30169</pub-id><?supplied-pmid 27503003?><pub-id pub-id-type="pmid">27503003</pub-id></element-citation></ref><ref id="B77-antibiotics-10-00231"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>T.</given-names></name><name><surname>Ozawa</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>N.</given-names></name><name><surname>Arai</surname><given-names>S.</given-names></name><name><surname>Mura</surname><given-names>K.</given-names></name></person-group><article-title><italic>Bacillus cereus</italic> response to a proanthocyanidin trimer, a transcriptional and functional analysis</article-title><source>Curr. Microbiol.</source><year>2016</year><volume>73</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1007/s00284-016-1032-x</pub-id><pub-id pub-id-type="pmid">27061585</pub-id></element-citation></ref><ref id="B78-antibiotics-10-00231"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>A.B.</given-names></name></person-group><article-title>Bioactive compounds in cranberries and their role in prevention of urinary tract infections</article-title><source>Mol Nutr Food Res</source><year>2007</year><volume>51</volume><fpage>732</fpage><lpage>737</lpage><pub-id pub-id-type="doi">10.1002/mnfr.200700038</pub-id><pub-id pub-id-type="pmid">17487930</pub-id></element-citation></ref><ref id="B79-antibiotics-10-00231"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeger</surname><given-names>R.</given-names></name><name><surname>Cuny</surname><given-names>E.</given-names></name></person-group><article-title>Terpenoids with special pharmacological significance: A review</article-title><source>Nat. Prod. Commun.</source><year>2016</year><volume>11</volume><fpage>1373</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.1177/1934578X1601100946</pub-id><?supplied-pmid 30807045?><pub-id pub-id-type="pmid">30807045</pub-id></element-citation></ref><ref id="B80-antibiotics-10-00231"><label>80.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Breitmaier</surname><given-names>E.</given-names></name></person-group><source>Terpenes: Flavors, Fragrances, Pharmaca, Pheromones</source><publisher-name>Wiley-VCH</publisher-name><publisher-loc>Weinheim, Germany</publisher-loc><year>2006</year></element-citation></ref><ref id="B81-antibiotics-10-00231"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdeguer</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez-Moreiras</surname><given-names>A.M.</given-names></name><name><surname>Araniti</surname><given-names>F.</given-names></name></person-group><article-title>Phytotoxic effects and mechanism of action of essential oils and terpenoids</article-title><source>Plants</source><year>2020</year><volume>9</volume><elocation-id>1571</elocation-id><pub-id pub-id-type="doi">10.3390/plants9111571</pub-id><?supplied-pmid 33202993?><pub-id pub-id-type="pmid">33202993</pub-id></element-citation></ref><ref id="B82-antibiotics-10-00231"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimar&#x000e3;es</surname><given-names>A.C.</given-names></name><name><surname>Martins Meireles</surname><given-names>L.</given-names></name><name><surname>Fumiere Lemos</surname><given-names>M.</given-names></name><name><surname>Cunegundes Guimar&#x000e3;es</surname><given-names>M.C.</given-names></name><name><surname>Coutinho Endringer</surname><given-names>D.</given-names></name><name><surname>Fronza</surname><given-names>M.</given-names></name><name><surname>Scherer</surname><given-names>R.</given-names></name></person-group><article-title>Antibacterial activity of terpenes and terpenoids present in essential oils</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2471</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24132471</pub-id></element-citation></ref><ref id="B83-antibiotics-10-00231"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zengin</surname><given-names>H.</given-names></name><name><surname>Baysal</surname><given-names>A.H.</given-names></name></person-group><article-title>Antibacterial and antioxidant activity of essential oil terpenes against pathogenic and spoilage-forming bacteria and cell structure-activity relationships evaluated by SEM microscopy</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>17773</fpage><lpage>17798</lpage><pub-id pub-id-type="doi">10.3390/molecules191117773</pub-id><?supplied-pmid 25372394?><pub-id pub-id-type="pmid">25372394</pub-id></element-citation></ref><ref id="B84-antibiotics-10-00231"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Araniti</surname><given-names>F.</given-names></name><name><surname>Landi</surname><given-names>M.</given-names></name><name><surname>Lupini</surname><given-names>A.</given-names></name><name><surname>Sunseri</surname><given-names>F.</given-names></name><name><surname>Guidi</surname><given-names>L.</given-names></name><name><surname>Abenavoli</surname><given-names>M.</given-names></name></person-group><article-title><italic>Origanum vulgare</italic> essential oils inhibit glutamate and aspartate metabolism altering the photorespiratory pathway in <italic>Arabidopsis thaliana</italic> seedlings</article-title><source>J. Plant Physiol.</source><year>2018</year><volume>231</volume><fpage>297</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.1016/j.jplph.2018.10.006</pub-id><?supplied-pmid 30343221?><pub-id pub-id-type="pmid">30343221</pub-id></element-citation></ref><ref id="B85-antibiotics-10-00231"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade-Ochoa</surname><given-names>S.</given-names></name><name><surname>Nev&#x000e1;rez-Moorill&#x000f3;n</surname><given-names>G.V.</given-names></name><name><surname>S&#x000e1;nchez-Torres</surname><given-names>L.E.</given-names></name><name><surname>Villanueva-Garc&#x000ed;a</surname><given-names>M.</given-names></name><name><surname>S&#x000e1;nchez-Ram&#x000ed;rez</surname><given-names>B.E.</given-names></name><name><surname>Rodr&#x000ed;guez-Valdez</surname><given-names>L.M.</given-names></name><name><surname>Rivera-Chavira</surname><given-names>B.E.</given-names></name></person-group><article-title>Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against <italic>Mycobacterium tuberculosis</italic> and <italic>Mycobacterium bovis</italic></article-title><source>BMC Complement. Altern. Med.</source><year>2015</year><volume>15</volume><elocation-id>332</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-015-0858-2</pub-id><pub-id pub-id-type="pmid">26400221</pub-id></element-citation></ref><ref id="B86-antibiotics-10-00231"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nostro</surname><given-names>A.</given-names></name><name><surname>Papalia</surname><given-names>T.</given-names></name></person-group><article-title>Antimicrobial activity of carvacrol: Current progress and future perspectives</article-title><source>Recent Pat. Antiinfect. Drug Discov.</source><year>2012</year><volume>7</volume><fpage>28</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.2174/157489112799829684</pub-id><pub-id pub-id-type="pmid">22044355</pub-id></element-citation></ref><ref id="B87-antibiotics-10-00231"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi-Rad</surname><given-names>M.</given-names></name><name><surname>Setzer</surname><given-names>W.N.</given-names></name><name><surname>Soltani-Nejad</surname><given-names>A.</given-names></name><name><surname>Varoni</surname><given-names>E.M.</given-names></name><name><surname>Iriti</surname><given-names>M.</given-names></name><name><surname>Martorell</surname><given-names>M.</given-names></name><name><surname>Contreras</surname><given-names>M.M.</given-names></name><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Rajabi</surname><given-names>S.</given-names></name><name><surname>Tajbakhsh</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Carvacrol and human health: A comprehensive review</article-title><source>Phytother. Res.</source><year>2018</year><volume>32</volume><fpage>1675</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1002/ptr.6103</pub-id><?supplied-pmid 29744941?><pub-id pub-id-type="pmid">29744941</pub-id></element-citation></ref><ref id="B88-antibiotics-10-00231"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Arciola</surname><given-names>C.R.</given-names></name><name><surname>Coppo</surname><given-names>E.</given-names></name><name><surname>Barbieri</surname><given-names>R.</given-names></name><name><surname>Barreca</surname><given-names>D.</given-names></name><name><surname>Chebaibi</surname><given-names>S.</given-names></name><name><surname>Sobarzo-S&#x000e1;nchez</surname><given-names>E.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name></person-group><article-title>The natural plant compound carvacrol as anti-microbial and anti-biofilm agent: Mechanisms, synergies and bio-inspired anti-infective materials</article-title><source>Biofouling</source><year>2018</year><volume>34</volume><fpage>630</fpage><lpage>656</lpage><pub-id pub-id-type="doi">10.1080/08927014.2018.1480756</pub-id><?supplied-pmid 30067078?><pub-id pub-id-type="pmid">30067078</pub-id></element-citation></ref><ref id="B89-antibiotics-10-00231"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchese</surname><given-names>A.</given-names></name><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Daglia</surname><given-names>M.</given-names></name><name><surname>Barbieri</surname><given-names>R.</given-names></name><name><surname>Di Lorenzo</surname><given-names>A.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Gortzi</surname><given-names>O.</given-names></name><name><surname>Izadi</surname><given-names>M.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name></person-group><article-title>Antibacterial and antifungal activities of thymol: A brief review of the literature</article-title><source>Food Chem.</source><year>2016</year><volume>210</volume><fpage>402</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.04.111</pub-id><pub-id pub-id-type="pmid">27211664</pub-id></element-citation></ref><ref id="B90-antibiotics-10-00231"><label>90.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>W.C.</given-names></name><name><surname>Evans</surname><given-names>D.A.</given-names></name></person-group><source>Trease and Evans&#x02019; Pharmacognosy</source><edition>16th ed.</edition><person-group person-group-type="editor"><name><surname>Evans</surname><given-names>W.C.</given-names></name><name><surname>Evans</surname><given-names>D.</given-names></name></person-group><publisher-name>W.B. Saunders</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2009</year><fpage>353</fpage><lpage>415</lpage></element-citation></ref><ref id="B91-antibiotics-10-00231"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dembitsky</surname><given-names>V.M.</given-names></name></person-group><article-title>Astonishing diversity of natural surfactants: 6. Biologically active marine and terrestrial alkaloid glycosides</article-title><source>Lipids</source><year>2005</year><volume>40</volume><fpage>1081</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1007/s11745-005-1473-2</pub-id><pub-id pub-id-type="pmid">16459921</pub-id></element-citation></ref><ref id="B92-antibiotics-10-00231"><label>92.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hesse</surname><given-names>M.</given-names></name></person-group><source>Alkaloids: Nature&#x02019;s Curse or Blessing?</source><publisher-name>Wiley-VCH</publisher-name><publisher-loc>Weinheim, Germany</publisher-loc><year>2002</year></element-citation></ref><ref id="B93-antibiotics-10-00231"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>R.</given-names></name><name><surname>Arora</surname><given-names>S.</given-names></name></person-group><article-title>Alkaloids-important therapeutic secondary metabolites of plant origin</article-title><source>J. Crit. Rev.</source><year>2015</year><volume>2</volume><fpage>1</fpage><lpage>8</lpage></element-citation></ref><ref id="B94-antibiotics-10-00231"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amirkia</surname><given-names>V.</given-names></name><name><surname>Heinrich</surname><given-names>M.</given-names></name></person-group><article-title>Alkaloids as drug leads&#x02014;A predictive structural and biodiversity-based analysis</article-title><source>Phytochem. Lett.</source><year>2014</year><volume>10</volume><fpage>xlviii</fpage><lpage>liii</lpage><pub-id pub-id-type="doi">10.1016/j.phytol.2014.06.015</pub-id></element-citation></ref><ref id="B95-antibiotics-10-00231"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Othman</surname><given-names>L.</given-names></name><name><surname>Sleiman</surname><given-names>A.</given-names></name><name><surname>Abdel-Massih</surname><given-names>R.M.</given-names></name></person-group><article-title>Antimicrobial activity of polyphenols and alkaloids in middle eastern plants</article-title><source>Front. Microbiol.</source><year>2019</year><volume>10</volume><fpage>911</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00911</pub-id><?supplied-pmid 31156565?><pub-id pub-id-type="pmid">31156565</pub-id></element-citation></ref><ref id="B96-antibiotics-10-00231"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casciaro</surname><given-names>B.</given-names></name><name><surname>Mangiardi</surname><given-names>L.</given-names></name><name><surname>Cappiello</surname><given-names>F.</given-names></name><name><surname>Romeo</surname><given-names>I.</given-names></name><name><surname>Loffredo</surname><given-names>M.R.</given-names></name><name><surname>Iazzetti</surname><given-names>A.</given-names></name><name><surname>Calcaterra</surname><given-names>A.</given-names></name><name><surname>Goggiamani</surname><given-names>A.</given-names></name><name><surname>Ghirga</surname><given-names>F.</given-names></name><name><surname>Mangoni</surname><given-names>M.L.</given-names></name><etal/></person-group><article-title>Naturally occurring alkaloids of plant origin as potential antimicrobials against antibiotic-resistant infections</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>3619</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25163619</pub-id></element-citation></ref><ref id="B97-antibiotics-10-00231"><label>97.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Caballero</surname><given-names>B.</given-names></name><name><surname>Finglas</surname><given-names>P.</given-names></name><name><surname>Toldra</surname><given-names>F.</given-names></name></person-group><source>Encyclopedia of Food and Health</source><publisher-name>Elsevier Science</publisher-name><publisher-loc>Amsterdam, The Netherlands</publisher-loc><year>2015</year><fpage>561</fpage></element-citation></ref><ref id="B98-antibiotics-10-00231"><label>98.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>R.L.</given-names></name></person-group><source>The 100 Most Important Chemical Compounds: A Reference Guide</source><publisher-name>Greenwood Press</publisher-name><publisher-loc>Westport, CT, USA</publisher-loc><year>2007</year><fpage>55</fpage></element-citation></ref><ref id="B99-antibiotics-10-00231"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>A.A.</given-names></name><name><surname>Farah</surname><given-names>A.</given-names></name><name><surname>Silva</surname><given-names>D.A.</given-names></name><name><surname>Nunan</surname><given-names>E.</given-names></name><name><surname>Gloria</surname><given-names>M.B.</given-names></name></person-group><article-title>Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>8738</fpage><lpage>8743</lpage><pub-id pub-id-type="doi">10.1021/jf0617317</pub-id><?supplied-pmid 17090115?><pub-id pub-id-type="pmid">17090115</pub-id></element-citation></ref><ref id="B100-antibiotics-10-00231"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakraborty</surname><given-names>P.</given-names></name><name><surname>Dastidar</surname><given-names>D.G.</given-names></name><name><surname>Paul</surname><given-names>P.</given-names></name><name><surname>Dutta</surname><given-names>S.</given-names></name><name><surname>Basu</surname><given-names>D.</given-names></name><name><surname>Sharma</surname><given-names>S.R.</given-names></name><name><surname>Basu</surname><given-names>S.</given-names></name><name><surname>Sarker</surname><given-names>R.K.</given-names></name><name><surname>Sen</surname><given-names>A.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Inhibition of biofilm formation of <italic>Pseudomonas aeruginosa</italic> by caffeine: A potential approach for sustainable management of biofilm</article-title><source>Arch. Microbiol.</source><year>2020</year><volume>202</volume><fpage>623</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1007/s00203-019-01775-0</pub-id><?supplied-pmid 31773197?><pub-id pub-id-type="pmid">31773197</pub-id></element-citation></ref><ref id="B101-antibiotics-10-00231"><label>101.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>Berberine</collab></person-group><article-title>PubChem, National Library of Medicine, U.S. National Institutes of Health</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="www.pubchem.ncbi.nlm.nih.gov">www.pubchem.ncbi.nlm.nih.gov</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2021-01-17">(accessed on 17 January 2021)</date-in-citation></element-citation></ref><ref id="B102-antibiotics-10-00231"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubreuil</surname><given-names>J.D.</given-names></name></person-group><article-title>Antibacterial and antidiarrheal activities of plant products against enterotoxigenic <italic>Escherichia coli</italic></article-title><source>Toxins</source><year>2013</year><volume>5</volume><fpage>2009</fpage><lpage>2041</lpage><pub-id pub-id-type="doi">10.3390/toxins5112009</pub-id><pub-id pub-id-type="pmid">24212181</pub-id></element-citation></ref><ref id="B103-antibiotics-10-00231"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sack</surname><given-names>R.B.</given-names></name><name><surname>Froehlich</surname><given-names>J.L.</given-names></name></person-group><article-title>Berberine inhibits intestinal secretory response of <italic>Vibrio cholerae</italic> and <italic>Escherichia coli</italic> enterotoxins</article-title><source>Infect. Immun.</source><year>1982</year><volume>35</volume><fpage>471</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1128/IAI.35.2.471-475.1982</pub-id><?supplied-pmid 7035365?><pub-id pub-id-type="pmid">7035365</pub-id></element-citation></ref><ref id="B104-antibiotics-10-00231"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>D.</given-names></name><name><surname>Courtney</surname><given-names>H.S.</given-names></name><name><surname>Beachey</surname><given-names>E.H.</given-names></name></person-group><article-title>Berberine sulfate blocks adherence of <italic>Streptococcus pyogenes</italic> to epithelial cells, fibronectin, and hexadecane</article-title><source>Antimicrob. Agents Chemother.</source><year>1988</year><volume>32</volume><fpage>1370</fpage><lpage>1374</lpage><pub-id pub-id-type="doi">10.1128/AAC.32.9.1370</pub-id><?supplied-pmid 3058020?><pub-id pub-id-type="pmid">3058020</pub-id></element-citation></ref><ref id="B105-antibiotics-10-00231"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D.C.</given-names></name><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Xiang</surname><given-names>H.</given-names></name><name><surname>Fan</surname><given-names>J.W.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>N.</given-names></name><name><surname>Feng</surname><given-names>H.</given-names></name><name><surname>Deng</surname><given-names>X.M.</given-names></name></person-group><article-title>Global transcriptional profiles of <italic>Staphylococcus aureus</italic> treated with berberine chloride</article-title><source>FEMS Microbiol. Lett.</source><year>2008</year><volume>279</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2007.01031.x</pub-id><pub-id pub-id-type="pmid">18179590</pub-id></element-citation></ref><ref id="B106-antibiotics-10-00231"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lv</surname><given-names>Z.</given-names></name><name><surname>Pen</surname><given-names>G.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name></person-group><article-title>Berberine blocks the relapse of <italic>Clostridium difficile</italic> infection in C57/BL 6 mice after standard vancomycin treatment</article-title><source>Antimicrob. Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>3726</fpage><lpage>3735</lpage><pub-id pub-id-type="doi">10.1128/AAC.04794-14</pub-id><?supplied-pmid 25824219?><pub-id pub-id-type="pmid">25824219</pub-id></element-citation></ref><ref id="B107-antibiotics-10-00231"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haptemarian</surname><given-names>S.</given-names></name></person-group><article-title>Berberine pharmacology and the gut microbiota: A hidden therapeutic link</article-title><source>Pharmacol. Res.</source><year>2020</year><volume>155</volume><fpage>104722</fpage><pub-id pub-id-type="doi">10.1016/j.phrs.2020.104722</pub-id><?supplied-pmid 32105754?><pub-id pub-id-type="pmid">32105754</pub-id></element-citation></ref><ref id="B108-antibiotics-10-00231"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Tian</surname><given-names>X.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Huang</surname><given-names>G.</given-names></name><name><surname>Cai</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Self-assemblies based on traditional medicine berberine and cinnamic acid for adhesion-induced inhibition multidrug-resistant <italic>Staphylococcus aureus</italic></article-title><source>ACS Appl. Mater. Interfaces</source><year>2020</year><volume>8</volume><fpage>227</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1021/acsami.9b17722</pub-id><?supplied-pmid 31829617?><pub-id pub-id-type="pmid">31829617</pub-id></element-citation></ref><ref id="B109-antibiotics-10-00231"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guzman</surname><given-names>J.D.</given-names></name></person-group><article-title>Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity</article-title><source>Molecules</source><year>2014</year><volume>19</volume><fpage>19292</fpage><lpage>19349</lpage><pub-id pub-id-type="doi">10.3390/molecules191219292</pub-id><?supplied-pmid 25429559?><pub-id pub-id-type="pmid">25429559</pub-id></element-citation></ref><ref id="B110-antibiotics-10-00231"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Lan</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Cao</surname><given-names>Y.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name></person-group><article-title>Capsaicin-the major bioactive ingredient of chili peppers: Bio-efficacy and delivery systems</article-title><source>Food Funct.</source><year>2020</year><volume>11</volume><fpage>2848</fpage><lpage>2860</lpage><pub-id pub-id-type="doi">10.1039/D0FO00351D</pub-id><?supplied-pmid 32246759?><pub-id pub-id-type="pmid">32246759</pub-id></element-citation></ref><ref id="B111-antibiotics-10-00231"><label>111.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>A.</given-names></name><name><surname>Rosani</surname><given-names>A.</given-names></name><name><surname>Quick</surname><given-names>J.</given-names></name></person-group><article-title>Capsaicin</article-title><source>StatPearls</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2020</year></element-citation></ref><ref id="B112-antibiotics-10-00231"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anand</surname><given-names>P.</given-names></name><name><surname>Bley</surname><given-names>K.</given-names></name></person-group><article-title>Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch</article-title><source>Br. J. Anaesth.</source><year>2011</year><volume>107</volume><fpage>490</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1093/bja/aer260</pub-id><?supplied-pmid 21852280?><pub-id pub-id-type="pmid">21852280</pub-id></element-citation></ref><ref id="B113-antibiotics-10-00231"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostrovsky</surname><given-names>D.A.</given-names></name></person-group><article-title>Single treatment with capsaicin 8% patch may reduce pain and sleep interference up to 12 weeks in patients with painful diabetic peripheral neuropathy</article-title><source>Explore</source><year>2017</year><volume>13</volume><fpage>351</fpage><lpage>353</lpage><pub-id pub-id-type="doi">10.1016/j.explore.2017.07.005</pub-id><?supplied-pmid 28915983?><pub-id pub-id-type="pmid">28915983</pub-id></element-citation></ref><ref id="B114-antibiotics-10-00231"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>N.P.</given-names></name><name><surname>Mahajan</surname><given-names>P.</given-names></name><name><surname>Mehra</surname><given-names>R.</given-names></name><name><surname>Nargotra</surname><given-names>A.</given-names></name><name><surname>Sharma</surname><given-names>J.P.</given-names></name><name><surname>Koul</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>I.A.</given-names></name></person-group><article-title>Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of <italic>Staphylococcus aureus</italic></article-title><source>J. Antimicrob. Chemother.</source><year>2012</year><volume>67</volume><fpage>2401</fpage><lpage>2408</lpage><pub-id pub-id-type="doi">10.1093/jac/dks232</pub-id><?supplied-pmid 22807321?><pub-id pub-id-type="pmid">22807321</pub-id></element-citation></ref><ref id="B115-antibiotics-10-00231"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J.</given-names></name><name><surname>Niu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Leng</surname><given-names>B.</given-names></name><name><surname>Dong</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Luo</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Capsaicin protects mice from community-associated methicillin-resistant <italic>Staphylococcus aureus</italic> pneumonia</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e33032</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0033032</pub-id><?supplied-pmid 22427935?><pub-id pub-id-type="pmid">22427935</pub-id></element-citation></ref><ref id="B116-antibiotics-10-00231"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marini</surname><given-names>E.</given-names></name><name><surname>Magi</surname><given-names>G.</given-names></name><name><surname>Mingoia</surname><given-names>M.</given-names></name><name><surname>Pugnaloni</surname><given-names>A.</given-names></name><name><surname>Facinelli</surname><given-names>B.</given-names></name></person-group><article-title>Antimicrobial and anti-virulence activity of capsaicin against erythromycin-resistant, cell invasive Group a Streptococci</article-title><source>Front. Microbiol.</source><year>2015</year><volume>13</volume><fpage>1281</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.01281</pub-id><?supplied-pmid 26617603?><pub-id pub-id-type="pmid">26617603</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="antibiotics-10-00231-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structure of four simple phenols with antibacterial activity.</p></caption><graphic xlink:href="antibiotics-10-00231-g001"/></fig><fig id="antibiotics-10-00231-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Structure of phenolic acids.</p></caption><graphic xlink:href="antibiotics-10-00231-g002"/></fig><fig id="antibiotics-10-00231-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Structure of main quinone groups, and two quinones with antibacterial properties, acacetin and thymoquinone.</p></caption><graphic xlink:href="antibiotics-10-00231-g003"/></fig><fig id="antibiotics-10-00231-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Structure of flavonoids.</p></caption><graphic xlink:href="antibiotics-10-00231-g004"/></fig><fig id="antibiotics-10-00231-f005" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Structure of tea catechins.</p></caption><graphic xlink:href="antibiotics-10-00231-g005"/></fig><fig id="antibiotics-10-00231-f006" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Structure of carvacrol and its isomer thymol.</p></caption><graphic xlink:href="antibiotics-10-00231-g006"/></fig><fig id="antibiotics-10-00231-f007" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Structure of 3 alkaloids: caffeine, berberine, and capsaicin.</p></caption><graphic xlink:href="antibiotics-10-00231-g007"/></fig><fig id="antibiotics-10-00231-f008" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Antibacterial action mechanisms of plant-derived compounds.</p></caption><graphic xlink:href="antibiotics-10-00231-g008"/></fig></floats-group></article>